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Poultry is one of the main sources of protein in the United States and in 2014 Americans 
ate approximately 100 lbs per person.  However, consumption of poultry products is strongly 
associated with foodborne illness from Campylobacter.  In the first study, chitosan, caprylic acid 
and their combination were evaluated as a coating treatment for the reduction of Campylobacter 
jejuni on poultry products.  For the initial screening trials, chitosan of three different molecular 
weights (15-50 kDa, 190-310 kDa and 400-600 kDa) was evaluated at three concentrations (0.5%, 
1.0%, 2.0%) and separately, caprylic acid was tested at 0.5%, 1.0% and 2.0% using chicken skin 
pieces.  From these initial screenings a solution of 2% medium molecular weight (190-310 kDa) 
chitosan was chosen for continued evaluation, as was 1% and 2% caprylic acid.  To determine 
short term and long term efficacy of the 2% chitosan, 1% caprylic acid, 2% caprylic acid 
individually and in combination wingettes were inoculated with Campylobacter, coated with a 
given treatment and sampled at 0, 1, 3, 5 and 7 days.  The 2% chitosan and both 1% and 2% 
caprylic acid continually reduced Campylobacter counts starting at day 3 through day 7.  The 
combination of either 1% or 2% caprylic acid plus 2% medium molecular weight chitosan 
continuously reduced Campylobacter starting at day 0 through day 5.  
In the second study Lactobacillus spp. isolates with in-vitro anti-Campylobacter activity 
were evaluated for their efficacy as a protective culture when applied to chicken wingettes.  An 
original 13 isolates of Lactobacillus were screened, resulting in the selection of 4 isolates for 
further evaluation.  Wingettes were inoculated with Campylobacter jejuni and treated with either 
a Lactobacillus broth culture or a BPD control, followed by sampling at days 0, 1, 3, 5 and 7.  All 
isolates were able to reduce Campylobacter counts by day 3, however two isolates produced more 
consistent reductions.  These two isolates were combined with a 2% chitosan solution (190-310 
kDa) and applied as a coating treatment for evaluation of increased efficacy.  The combination of 
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Campylobacter is a common contaminant of poultry carcasses and raw retail poultry 
products (Conner et al., 2001; Suzuki and Yamamoto, 2009; USDA FSIS, 2009).  This bacterium 
is a consistent inhabitant of the gut microflora of poultry, with the capability to colonize at high 
levels without negatively impacting the health of the bird (Blaser et al., 1983; Evans, 1991; Jacobs-
Reitsma et al., 1995; Hermans et al., 2012; Wagenaar et al., 2015).  Foodborne illness resulting 
from infection with Campylobacter is highly associated with consumption of poultry products and 
the mishandling of raw and cooked poultry (Wilson et al., 2008; Painter et al., 2013; Bondi et al., 
2014).  Campylobacter contamination of poultry meat is a significant problem because it is 
consumed as one of the major sources of protein in the United States and indeed globally (AVEC, 
2013, 2014; National Chicken Council, 2015; USDA and Foreign Agricultural Service, 2015).  
The implications of this being that increased consumption will result in a higher frequency of 
illness even if the contamination rate is low (Painter et al., 2013; Wagenaar et al., 2015).  This 
stresses the importance of the need for effective intervention strategies to reduce Campylobacter 
on raw poultry.  The decontamination of poultry during processing and packaging is a complex 
problem from many aspects.  Unlike other food animals, the skin of poultry is not removed during 
first processing which may lead to pathogenic bacteria becoming attached to or trapped in the folds 
of skin or feather follicles which can contribute to cross-contamination along the production line 
(Lillard, 1989; Corry and Atabay, 2001; Wagenaar et al., 2013).  Additionally, poultry products 
pose challenges when applying surface antimicrobial compounds due to their heterogeneous 
characteristics, high pH and high protein and fat content (Davidson et al., 2014).   
In the U.S. today there is a growing trend amongst consumers for knowledge about how 
food commodities are grown, processed and packaged—with increased focus on minimized 
processing and chemical treatment (Gyawali and Ibrahim, 2014; Sánchez-Ortega, 2014).  As a 
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response to these desires food production companies have an increased interest in methods of 
making foods microbiologically safe by more natural interventions or treatments.  A potential 
option for naturally safer product is by utilizing antimicrobial packaging or coating treatments 
(Cagri et al., 2004; Salleh et al., 2007; Pavlath and Orts, 2009; Sánchez-Ortega, 2014).  The use 
of coating treatments on raw poultry products can be considered another intervention to add to the 
multiple hurdle approach for enhancing the food safety of poultry products (Ricke and Hanning, 
2013).  An important aspect of any food coating or material in contact with food is the 
understanding that the material must be food grade and frequently require designation by the FDA 
as Generally Recognized as Safe (GRAS)—additionally and edible coating is considered a food 
additive and GRAS status is necessary to demonstrate that the coating material is safe within the 
parameters of how it is used in the food (Pavlath and Orts, 2009; FDA, 2015). 
The use of chitosan as an antimicrobial food coating and preservative is receiving increased 
attention owing to the many biological characteristics which are beneficial for its application in 
the food industry (Dutta et al., 2009).  According to the literature chitosan based coatings are: (1) 
non-toxic and non-polluting; (2) possess antimicrobial/antifungal activity; (3) are low cost and 
abundant; (4) edible; (5) biodegradable; and (6) have positive chemical properties for ease of 
industrial use (Kong et al., 2010; Aider, 2010; Sánchez-González et al., 2011; Elsabee and Abdou, 
2013).  The approval of the use of chitosan as a coating is already in place in Canada and while 
not GRAS in the U.S. it is expected to be approved by the FDA in the near future (Baldwin, 2007; 
Vasilatos and Savvaidis, 2013; Zivanovic et al., 2014).  Menconi and colleagues (2013) were able 
to reduce Salmonella Typhimurium and extend the shelf-life of chicken skin treated with a 0.5% 
chitosan solution.  The use of chitosan and its incorporation with natural compounds for the 
treatment of poultry products to extend shelf-life and reduce pathogens has also generated 
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increased interest. Petrou and colleagues (2012) successfully extended the shelf-life of MAP 
packaged chicken breast fillets by 6–12 days with the application of 1.5% chitosan or 1.5% 
chitosan plus oregano oil. The combination of chitosan and thyme essential oil significantly 
reduced spoilage organisms, Enterobacteriacae and lactic acid bacteria on packaged chicken 
kebabs after 12 days of storage as compared to the controls (Giatrakou et al., 2010). 
A potential surface treatment for poultry meat is the naturally occurring fatty acid caprylic 
acid, a medium chain fatty acid found in mammalian milk, palm kernel oil and coconut oil.  It is 
designated by the FDA (FDA, 2014) as a multipurpose food ingredient and the EPA has approved 
it as a sanitizer for use on inanimate objects (EPA, 2014).  Caprylic acid has broad spectrum 
antibacterial activity, and specific activity against the foodborne illness causing organisms Listeria 
monocytogenes, E.coli O157:H7, Staphylococcus aureus, Salmonella spp. and Campylobacter 
spp. (Kabara et al., 1972; Wang and Johnson, 1992; McLay et al., 2002; Nair et al., 2004; 
Skrivanova et al., 2007).  Riedel and colleagues (2009) treated chicken skin and meat with a 5.0% 
concentration of caprylic acid sodium salt and produced reductions in Campylobacter counts by 
up to 2.84 log10 on skin and 4 log10 on meat after treatment and storage at 4
0C for 24 hours. 
An additional strategy under evaluation to reduce foodborne pathogens on poultry products 
is the use of protective cultures.  The concept of protective cultures involves the addition of viable 
bacteria to food products that will inhibit pathogenic microorganisms by the production of 
metabolites which are antimicrobial (Holzapfel et al., 1995; Schillinger et al., 1996; Gálvez, 
Antonio et al., 2010; Garcia et al., 2010; Gaggia et al., 2011).  It has been suggested by 
Maragkoudakis and colleagues (2009) that the use of lactic acid bacteria as a protective culture on 
poultry meat is a feasible and safe option due to their ubiquitous nature in the foods we already 
consume they have been identified as a constituent of normal flora in the human gut microbiome 
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and these organisms have essentially been a part of our diet for thousands of years without 
significant negative implications.  Protective cultures that can be consumed by humans are most 
frequently from the genus Lactobacillus (Gibson, 2008; Fliss et al., 2011; Davidson et al., 2014).  
There is very little information in the literature in regards to the application of protective cultures 
to specifically inhibit Campylobacter.  Work by Melero and colleagues (2012, 2013) has evaluated 
the impact of protective cultures to reduce Campylobacter jejuni and Listeria monocytogenes in 
chicken products.  A protective culture of Bifidobacterium longum was used to treat chicken legs 
artificially inoculated with C. jejuni and packaged under modified atmosphere, and they observed 
a reduction in C. jejuni counts (1.09 log CFU/g) between days 6 – 9 of the study (Melero et al., 
2013).   
Justification: 
Foodborne infection with Campylobacter is a public health concern and the rates of illness 
have remained stagnant over the last two years.  Currently there are no treatments to eliminate 
Campylobacter from colonizing the gastrointestinal tract of poultry.  This stresses the importance 
for interventions during processing and at final packaging that reduce or eliminate the 
contamination of poultry products with Campylobacter.  Current trends in consumer preference 
include a desire for a more natural product—minimally processed and no chemical treatments.  
There is very little literature on the use of natural antimicrobials or protective cultures to reduce 
Campylobacter counts on poultry products.  More research is needed to find effective natural 
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2.1 Brief History of Campylobacter  
In so far as bacterial foodborne agents are concerned Campylobacter is a relative 
newcomer. Although its presence was first described by Theodore Escherich in 1886 (1886) and 
later confirmed to cause septic abortion in cattle and sheep (McFadyean and Stockman, 1909), it 
remained an organism primarily of veterinary concern up until the 1970's (Altekruse et al., 1999). 
The large gap in time from first observation to realization of the endemic nature of the organism 
can be attributed to its growth requirements and the necessity of selective culturing techniques in 
order to obtain pure cultures for study (Butzler, 2004). Human infection with Campylobacter in 
the 1940's and 1950's was diagnosed through direct observation of the suspected organism from 
blood of people suffering with gastroenteritis. The advancements in the detection of 
Campylobacter from human specimens began in the early 1970's. It was through a series of small 
steps that we have currently arrived at the ability to routinely culture this organism from infected 
patients, environmental sources and food matrices. Initially, researchers Cooper and Slee (1971) 
observed that an isolate of Campylobacter was able to grow in the presence of the antibiotic 
cephalothin when incubated in a microaerophilic atmosphere—leading to the first method 
available to laboratorians to help isolate Campylobacter. The main obstacle to isolation of 
Campylobacter from people with diarrhea was the overgrowth of other organisms present in the 
stool. The following year, Dekeyser and Butzler (1972) published a protocol utilizing a filtration 
technique which allowed the Campylobacter to be separated from other bacteria in the stool sample 
due to their relatively small size. Further progress was made by Martin Skirrow, when in 1977 he 
published a selective culture technique that was less labor intensive but with equal or greater 
sensitivity than the filtration technique (Skirrow, 1977). To validate this method he used the new 
technique over an 18 month period to culture for Campylobacter and other known bacterial 
 13 
 
pathogens; he was able to determine that Campylobacter was responsible for diarrhea and 
gastroenteritis in people that also had blood cultures positive for the presence of Campylobacter 
(Skirrow, 1977). This research combined with earlier work from King in 1957 (1957) and 
Dekeyser in 1972 (1972) led to the suspicion that Campylobacter may be one of the most frequent 
causes of infective acute diarrhea. In the early history of Campylobacter infection of humans, it 
was isolated only infrequently from body sites believed to be sterile, or from severely ill people 
presenting with bacteremia or septicemia. However, work published by Blazer in 1979 (Blaser et 
al., 1979) redefined the role of Campylobacter in human disease from one of a perceived 
opportunist to its significantly greater role as a frequent cause of acute gastroenteritis. From this 
point onward it was recognized that Campylobacter was pathogenic to humans. 
2.2 Morphology and In-Vitro Culture Conditions 
In the earliest history of what is now classified as Campylobacteriaceae, it was a 
recognized veterinary pathogen and assumed related to the genus Vibrio (McFadyean and 
Stockman, 1909). A few years later Smith and Taylor found a similarly described organism in 
tissues from aborted cattle fetuses and classified them as Vibrio fetus (Smith and Taylor, 1919). It 
was not until 1963 that researchers were able to classify the unusual Vibrio fetus as a distinct genus 
which they named Campylobacter fetus (Sebald and Veron, 1963). The name Campylobacter 
derives from the Greek words kampylos (curved) and baktron (rod) as this concisely describes the 
morphology of the bacterium. At the present time the family Campylobacteraceae is composed of 
3 genera: Campylobacter, Sulfurospirillum and Arcobacter (Debruyne et al., 2008). Upon direct 
observation Campylobacter appear as small (0.2 to 0.8µm) curved or S-shaped, non-spore forming 
Gram negative rods with a single polar flagella at one or both ends of the cell (Debruyne et al., 
2008). It is the polar flagella that give Campylobacter its most recognizable morphological feature 
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of tumbling, falling or corkscrew motility. A distinguishing characteristic of the genus 
Campylobacter are its growth requirements. It requires reduced atmospheric oxygen (5% O2, 10% 
CO2 and 85% N2) and grows best at 41.5
0C, however it is capable of growth at temperatures of 
300C to 450C (Robyn et al., 2015). 
As of 2013, 24 known species of Campylobacter and 8 subspecies have been identified 
ranging in origin from environmental, human or animal sources. In addition, there are 14 
completely sequenced genomes of Campylobacter species in the National Center for 
Biotechnology Information (NCBI) genome database available for more in depth molecular 
analysis (Pruitt et al., 2002). This has been a valuable resource for investigation into the potential 
mechanisms which lead to the high degree of genetic variability both within and among 
Campylobacter strains.  
While there are many species of Campylobacter, clinical data indicates that humans are 
most frequently sickened by C. jejuni and less frequently with C. coli, C. lari and C. upsalensis 
(Friedman, 2000; Gillespie et al., 2002; Taboada et al., 2013). Infection with Campylobacter is by 
ingestion through the oral route, as most illness is caused by eating or drinking contaminated foods. 
The number of bacteria that survive the acidic environment of the stomach depends upon the 
buffering capacity of the food that was ingested along with the bacteria (Janssen et al., 2008). 
Several studies have been undertaken to determine the infective dose of Campylobacter which will 
lead to disease. And from the reported results it was determined that the material with which the 
bacterium is ingested plays a role in the rate of infectivity, as demonstrated by low levels of 
Campylobacter contamination in milk correlating with illness (Robinson, 1981). Data from Black 
(1988) and Medema (1996) indicate that as low as 500-800 cells can result in a high probability of 
infection, which makes it more infective than other bacterial pathogens including Salmonella spp., 
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but the dose to initiate disease could not be determined. General symptoms of illness include fever, 
malaise, abdominal pain, diarrhea and fever within 24 to 48 hours of exposure to the bacterium 
(Blaser et al., 1987; Wood et al., 1992). From epidemiological studies of Campylobacter 
outbreaks, in which a source was identified, the duration from exposure to illness is variable and 
can occur between 1 - 7 days, but 24 to 48 hours is the most common (Blaser et al., 1987; Wood 
et al., 1992). For most people, development of illness occurs within 3 days of an exposure and 
leads to a self-limiting illness with a duration of less than a week—however continued fecal 
excretion of the bacteria can last for an average of 16 days and up to 69 days has been documented 
(Blaser, 1997; Wassenaar and Blaser, 1999; Kapperud et al., 2009). 
2.3 Human Infection Associated with Campylobacter 
Upon passage through the stomach Campylobacter adheres to the epithelial cells and the 
mucus layer of the intestines and proliferates (Janssen et al., 2008). Then, once infection and 
colonization has taken place, a person may become an asymptomatic carrier (Christenson et al., 
1983; Cawthraw et al., 2000) or diarrheal illness may proceed (Blaser et al., 1979). The disease 
manifestation of Campylobacter enteritis can be generally grouped into two categories (Hu and 
Kopecko, 2000) i) a secretory non-inflammatory diarrhea resulting from alterations in fluid 
resorption in the intestines from toxins (Wassenaar, 1997) or ii) bloody diarrhea as a result of the 
inflammatory response to Campylobacter invasion and proliferation within the intestinal mucosa 
(Janssen et al., 2008). In rare cases, intestinal infection with Campylobacter can produce 
cholecystitis, pancreatitis, or significant hemorrhage of the gastrointestinal tract (Acheson and 
Allos, 2001). Campylobacter is also capable of extraintestinal infection, though it is very rare. 
When Campylobacter disseminates beyond the intestinal tract, meningitis, endocarditis, septic 
arthritis osteomyelitis, sepsis or bacteremia can occur (Acheson and Allos, 2001). People that are 
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immunocompromised, very young or advanced in age are most susceptible to these more severe 
disease outcomes (Acheson and Allos, 2001; Samuel et al., 2004; Louwen et al., 2012). While no 
exact number of immunocompromised people in the United States has been calculated, the number 
is estimated at approximately 10 million or 3.6% of the population (Kemper et al., 2002). 
Ultimately, the severity of the disease in humans is determined by the specific strain of bacterium 
and factors of the host including immune system status (Newell, 2002). 
2.3.1 Sequelae Following Infection with Campylobacter 
Very soon after the development of selective stool culture techniques to isolate 
Campylobacter, researchers found connections between development of acute paralysis and prior 
infection with Campylobacter. Doctors were already aware of the link between gastrointestinal 
illness and development of what was then termed acute infective polyneuritis (Campbell, 1958). 
However, clinical proof of was not published until 1982 by Rhodes and and Tattersfield (1982) 
which documented a confirmed infection with Campylobacter and subsequent development of loss 
of motor development function, known as Guillain-Barre´ Syndrome (GBS). It is now accepted 
that post-infection diseases including Guillain-Barre´ syndrome / Miller Fischer Syndrome 
(Hughes and Cornblath, 2005; Fujimura, 2013), Reactive Arthritis (ReA) (Hannu, 2002), and 
immunoproliferative small intestinal disease (alpha chain disease) (Lecuit et al., 2004) are serious 
medical conditions that can develop after infection with Campylobacter.  
2.3.2 Guillain-Barre´ Syndrome (GBS) 
Guillain-Barre´ Syndrome, and its variant Miller Fischer Syndrome, are severe 
neurological diseases characterized by a rapid onset of weakness and tingling in the extremities 
progressing to ascending symmetrical loss of muscular function caused by biological mimicry of 
Campylobacter antigens and human gangliosides resulting in cross-reactive antibodies that attack 
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the peripheral nerves. The pathogenesis of GBS is rooted in the molecular mimicry between the 
lipooligosaccharides (LOS) on the surface of Campylobacter and the resultant production of 
antibodies that mimic areas on gangliosides within the peripheral nerves. Investigation has 
demonstrated that some Campylobacter jejuni serotypes have LOS in its outer core that 
coincidentally share similar antigenic epitopes to a large number of human peripheral nerve 
gangliosides (Yuki, 1997; Sheikh et al., 1998; Ang et al., 2000). According to Godschalk and 
colleagues (2004) it is estimated that between 50-60% of Campylobacter jejuni isolates are capable 
of producing and expressing the ganglioside mimicking sugars on their outer surface.  
 
Guillain-Barre´ Syndrome is now classified as a clinical syndrome caused by an acute 
inflammatory condition of the nervous system (Winer, 2014). The current classification scheme 
divides GBS into subtypes based upon neurological symptoms as related to potential different 
immunological mechanisms (Winer, 2014; Wakerley et al., 2014). The 3 subtypes are listed as: 
acute inflammatory demyelinating polyradiculoneuropathy (AIDP); acute motor axonal 
neuropathy (AMAN) and acute motor and sensory axonal neuropathy (AMSAN) (van Doorn et 
al., 2008; Winer, 2014). Miller Fisher syndrome is considered a variant of GBS and has distinct 
clinical presentations which include paralysis of eye muscles (ophthalmoplegia), loss of muscle 
coordination (ataxia), or loss of reflexes (areflexia)—and can then be further subdivided into 
incomplete and central nervous system subtypes (Mori and Kuwabara, 2011; Wakerley et al., 
2014) 
The likelihood of development of GBS after Campylobacter infection is quite low, and in 
the U.S. estimates are 1 in every 1058 infections may lead to GBS (Buzby et al., 1997). It is 
estimated that worldwide incidence of GBS is 1/100,000 (Yuki et al., 1993; Oomes and Jacobs, 
1995; McGrogan et al., 2009; Sejvar et al., 2011). The first symptoms of the onset of GBS occur 
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between 10 days to 3 weeks after infection with Campylobacter (Blaser et al., 2008; Winer, 2014). 
Development of GBS is a very serious condition, reports indicate that approximately 25% of GBS 
patients require ventilation (Lawn et al., 2001) and between 3 -5% of patients die (Souayah et al., 
2008). Disease progression reaches its apex at approximately 4 weeks followed by gradual 
improvements with 60% of patients regaining the ability to walk unassisted by 1 year (Winer, 
2014). Continual fatigue, pain and neurological disorders are a complication from GBS (Winer, 
2014). The outcome from GBS is varied and partially dependent upon host factors and 
Campylobacter strain. 
2.3.3 Reactive Arthritis 
Infection with Campylobacter can also trigger the development of a type of 
spondyloarthropathic disorder known as reactive arthritis (ReA) (Carter, 2006). Reactive arthritis 
was first described in 1969 (Ahvonen et al., 1969) and has since been utilized to describe a 
condition of acute joint inflammation with sterile synovial fluid that develops after a 
gastrointestinal or genitourinary infection (Berden et al., 1979; Carter, 2006). The connection 
between development of ReA and the confirmed antecedent of Campylobacter infection was first 
described in the late 1970's (Urman et al., 1977; Berden et al., 1979; Weir et al., 1979). Prior to 
the discovery of Campylobacter as a possible bacterium associated with ReA, it was already 
recognized that Salmonella, Shigella and Yersinia infection could lead to the development of ReA 
(Carter, 2006). The general symptoms of ReA include joint, tendon, skin, mucosal, or ocular pain 
and inflammation with possible malaise and fever (Carter, 2006). The onset of ReA is in general 
within 1 to 6 weeks of the initial bacterial infection (Carter, 2006; Singh and Karrar, 2014). As 
techniques in biology have continued to improve, analysis of synovial fluid has shown evidence 
of lipopolysaccharide and bacterial products of gram negative bacteria locating to these areas 
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(Carter, 2006). It has been suggested that these gram negative organisms pass through the mucus 
membranes in the gastrointestinal or genitourinary tract and travel to synovial tissues or fluid 
(Singh and Karrar, 2014). Current research on ReA has focused on the host-bacterium interaction 
then progressing to an autoimmune response causing the body to target the synovial space (Singh 
and Karrar, 2014). In 2000, researchers proposed a working classification scheme to try and assist 
with diagnosis of ReA (Braun et al., 1999). However, the diagnosis of ReA is not straightforward, 
as of 2013 there were no established diagnostic criteria (Ajene et al., 2013). Data on the rate of 
incidence of ReA following Campylobacter infection vary widely, Hannu and colleagues (2002) 
analyzed data suggesting the rate is 4.3 per 10,000 infections, while Ajene and colleagues (Ajene 
et al., 2013) determined it to be 9 per 1000 infections. The duration and resolution of ReA 
symptoms are also quite varied. It is reported that approximately half of all ReA conditions 
spontaneously resolve while the remaining half develop recurring long lasting arthritis (Carter, 
2006). Medical care for people with ReA may last for over 1 year and include frequent interactions 
with medical personnel (Porter et al., 2013).  
   
2.4 Campylobacter in the Environment 
All the newly acquired information regarding Campylobacter that culminated from the 
work in the 1970's through 80's led to a great interest from public health officials to determine the 
true rates of illness and to try to determine its etiology. Research regarding sources of 
Campylobacter has demonstrated that it can be found in domestic animals, livestock and in the 
environment. Isolation from environmental sources has included abattoir effluent, surface water, 
sand, animal feces, shellfish and protozoa (Jones, 2001; Skelly and Weinstein, 2003; Axelsson-
Olsson et al., 2005). While it is assumed that Campylobacter cannot multiply outside of a warm 
blooded host, studies have demonstrated that it is capable of persisting for extended periods of 
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time if given a favorable environment, which would include protection from direct sunlight and a 
cool moist atmosphere (Jones, 2001). Campylobacter has been isolated from many animals 
sources, and we now know it is a common inhabitant of the gastrointestinal system of domestic 
and wild animals (Blaser et al., 1983). Reservoirs for infection can include the animals we are most 
frequently surrounded by including domestic pets, and animals we utilize for food (Blaser et al., 
1983). In addition to the wide variety of hosts from which Campylobacter jejuni has been isolated, 
further research has demonstrated that there is a large proportion of strain diversity within C. jejuni 
strains found in these different hosts and some strains exhibit host specificity (Griekspoor et al., 
2013). Of particular importance to human health is the research which indicates that certain genetic 
populations of Campylobacter jejuni strains are widely distributed between hosts including food 
animals and humans—which may increase its potential as a zoonotic pathogen (Griekspoor et al., 
2013).  
2.5 Rates of Human Illness from Campylobacter 
The CDC has been monitoring Campylobacter infections since 1982 and started with an 
initial 11 states (Finch and Riley, 1984). In July of 1995 the Foodborne Diseases Active 
Surveillance Network (FoodNet) was initiated (CDC, 2012). This network of 10 state health 
departments along with USDA, FDA and CDC provides active surveillance of laboratory 
diagnosed infections from 8 bacterial pathogens, including Campylobacter, that are most 
frequently transmitted through food. The goal of this program is to provide reports on trends in 
foodborne illness and analyze the impact of national food safety policy. The most recent data 
published by FoodNet provides preliminary estimates of the number of Campylobacter infections 
for 2013 at 6,621 including 1,010 hospitalizations and 12 deaths (Crim et al., 2014). It is important 
for our understanding of these numbers to realize that the true number of infections is 
 21 
 
underreported, as diagnosed infections only account for an estimated 1 in 20 to 1 in 30 illnesses 
(Scallan et al., 2011; CDC, 2012). When adjusted for multiple factors, it is estimated that the true 
numbers of illnesses caused by food contaminated with Campylobacter is 1.3 million per year 
(Scallan et al., 2011).  
2.5.1 Culture Independent Diagnostic Tests (CIDTs) for Campylobacter 
Interestingly, quite recently some clinical labs have adopted the usage of culture 
independent diagnostic tests (CIDTs) in the diagnosis of enteric infections. In a report by Crim 
and colleagues (Crim et al., 2014) they note that of the 1,017 cases of positive CIDT for 
Campylobacter 42% came from samples that were not cultured for the bacterium and 58% were 
negative upon laboratory culture. While this technology is a great improvement for the ability to 
determine the causative agent of an infection—it does not integrate into our current model of 
foodborne illness tracing which involves characterization of bacterial isolates to detect clusters of 
similar pulsotypes (Cronquist et al., 2012; Braden and Tauxe, 2013). Wide spread adoption of 
these testing methods may increase the numbers of diagnosed infections without increasing the 
ability to detect trends and clusters of infection (Cronquist et al., 2012; Braden and Tauxe, 2013). 
This is especially important in regards to Campylobacter, due in great part to the relative difficulty 
of culturing the organism, the lack of a common standardized protocol used in clinical laboratories 
which could potentially lead to more reliance on CIDTs  (Cronquist et al., 2012; Crim et al., 2014). 
2.5.2 The Viable but Non-Culturable (VNBC) State for Campylobacter 
Campylobacter is also one of the growing list of pathogenic bacteria that are capable of 
entering into a stasis like existence that has been termed viable but non-culturable (VNBC) when 
encountering periods of stress (Oliver, 2010). The importance of the VNBC state in regards to 
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poultry processing and raw retail product is due to the multiples stressors during processing 
(including reduced pH and starvation conditions) that may induce the VNBC state and the resultant 
potential for bacterial survival for long periods of time (Chaveerach et al., 2003; Mihaljevic et al., 
2007). During the VNBC state the bacterium is unable to be resuscitated with normal culturing 
techniques (Oliver, 2000a; Li et al., 2014). The change from viable to non–culturable in 
Campylobacter also results in a morphological change from spiral or curved shaped to a coccoid 
shape (Rollins and Colwell, 1986). Bacterial cells are induced into the non–culturable state by 
environmental stressors including lack of nutrients, temperature shifts and osmotic stress (Oliver, 
2000b). This is important in the context of food safety and production because these stressors are 
among many of the methods employed to eliminate pathogens during food processing (Oliver, 
2005). It has also been reported that Campylobacter in the VNBC state has an increased tolerance 
to low pH, salinity, ethanol and chlorine (Rowe et al., 1998). Campylobacter cells that have entered 
the VNBC state have been brought back to culturability with the use of embryonic chicken eggs 
as the host (Cappelier et al., 1999; Talibart et al., 2000). Currently the mechanisms which enable 
a bacterium to be brought out of the VNBC state are unknown, but it is suspected that it is a result 
of bacterial-host interaction (Li et al., 2014). There is still dispute about the virulence potential 
VNBC Campylobacter cells and their level, if any, of infectivity (Oliver, 2005). But given the data 
from the embryonic egg model, it is most prudent to assume that VNBC cells of Campylobacter 
have the potential to be a risk factor for humans and animal infection alike (Talibart et al., 2000). 
In addition, the current gold standard to detection and enumeration of Campylobacter in animals 
and environmental samples is culture on selective media, and with the loss of culturability there 
can be an underestimate of the number of viable cells which may lead to negative health impacts 
(Li et al., 2014).  
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2.5.3 Campylobacter and Biofilm Formation 
In the laboratory environment Campylobacter has very particular growth conditions and 
can prove quite challenging. It has been demonstrated to be sensitive to sodium chloride 
concentrations of greater than 2% w/v, desiccation, atmospheric oxygen, freezing, heat and pH 
below 4.9 or above 9.0 (Solomon and Hoover, 1999; Martı́nez-Rodriguez et al., 2004; Murphy et 
al., 2006; Wagenaar et al., 2015). However, Campylobacter is commonly found in environmental 
sources which would seem inhospitable. Much research on Campylobacter in the environment has 
shown that it is capable of survival in water, agricultural runoff, manure compost, and in frozen 
poultry products (Blaser et al., 1983; Friedman et al., 2004; Martı́nez-Rodriguez et al., 2004; 
Nicholson et al., 2005; Havelaar et al., 2007; Inglis et al., 2010). Another potential mechanism 
which Campylobacter may utilize for survival in times of stress is the ability to become part of or 
produce biofilms.  (Reeser et al., 2007; Reuter and Mallett, 2010; Siringan et al., 2011; Ica et al., 
2012). Biofilms are composed to sessile bacterial colonies from either single of multiple species 
of bacteria, which become covered in an extracellular matrix (Siringan et al., 2011). 
Campylobacter has been found in biofilms located within the gastrointestinal tract of animals and 
in industrial settings including water pipes, which could serve as a potential reservoir for infecting 
food animals (Brown et al., 2014). Biofilms are advantageous for bacteria because they serve as a 
mechanism for survival during periods of stress, and in addition provide increased resistance to 
disinfectants, antimicrobials and antibiotics (Reuter and Mallett, 2010; Sofos and Geornaras, 
2010). In the poultry processing environment biofilms have been detected on many food contact 
surfaces including conveyor belts and stainless steel tables, which may become sources of 
contamination for foodstuffs with pathogenic organisms including Campylobacter (Lindsay et al., 
1996; Peyrat et al., 2008). Interestingly Reuter and colleagues (2010) documented that biofilm 
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formation by Campylobacter was increased in the presence of atmospheric oxygen and Brown and 
colleagues (2014) determined that juice from poultry meat can act as a conditioning agent on 
abiotic surfaces and enhance the ability of the bacterium to attach to biofilms. It is most recently 
proposed that Campylobacter in a food production environment is unlikely to create de novo 
biofilms and instead attaches and survives within already established multi-species biofilms (Teh 
et al., 2014). 
2.5.4 Human Sources of Infection with Campylobacter 
While it is recognized that there are at least 24 species of Campylobacter, data from 
confirmed cases of campylobacteriosis indicates that up to 90% of infections are with C. jejuni 
and the remaining 10% is made up of C. coli, C. lari and C. upsaliensis (Friedman, 2000; Gillespie 
et al., 2002; Taboada et al., 2013). Epidemiological analysis has determined that the major vehicles 
for human exposure to Campylobacter include untreated water, consumption of raw milk, produce 
and consumption of contaminated poultry products (Friedman et al., 2004; Taylor et al., 2013). 
Outbreaks of campylobacteriosis are rare and most frequently are caused by the consumption of 
unpasteurized dairy products (Taylor et al., 2013). Produce is also on the rise as a source for 
Campylobacter and the FDA is in the development stages of updating the food safety regulations 
for fresh produce (FDA, 2009; Taylor et al., 2013). The majority of human illness in the United 
States caused by Campylobacter are classified as sporadic and therefore are not epidemiologically 
linked to an outbreak (CDC, 2009). However, Wilson and colleagues (Wilson et al., 2008) claim 
that up to 97% of sporadic cases of Campylobacter are related to consumption of poultry and beef 




The area of source attribution is a rapidly growing methodology which seeks to provide an estimate 
of relative contribution of all reservoirs towards the total amount of human illness (Wagenaar et 
al., 2015). The full potential of this model is focused upon risk assessment, providing information 
in order to direct intervention efforts on the most important sources of infection (Wagenaar et al., 
2015). The current proposed framework utilizes two main approaches to Campylobacter 
attribution 1) microbiological and 2) epidemiological (WHO, 2012; Wagenaar et al., 2013). 
Analysis of data from Campylobacter infections that were utilized in the source attribution 
model for both the microbiology and epidemiology pathways concluded that poultry, specifically 
chicken is responsible for the majority of infections (Wagenaar et al., 2015). However, it should 
be noted that other pathways to exposure with Campylobacter including infected domestic animals 
and agricultural exposure are also responsible for human illness (Wagenaar et al., 2013). Most 
commonly, contact with poultry and poultry products are the leading cause of Campylobacter 
infection in humans (Harris et al., 1986; Wilson et al., 2008). Painter and colleagues (Painter et 
al., 2013) analyzed outbreak data as a result of foodborne illness between 1998-2008 in order to 
determine food commodities linked to illness. They determined that poultry was a significant 
commodity that was linked to bacterial foodborne illness, poultry was also the source of the most 
deaths (Painter et al., 2013). More specifically the Campylobacter-poultry combination accounted 
for an estimated $1257 million in health care related costs (Painter et al., 2013). In 2013 the United 
States processed over 8,500,000 broiler chickens and in 2012 the average per capita consumption 
of broiler meat was 83.1 lbs, by comparison the per person consumption of beef for the same year 
was 57.4 lbs (North American Meat Institute, 2015; U.S. Poultry and Egg, 2015). Chicken has 
become a popular choice as a food source due to its relative low price and high protein content. So 
it should be recognized that the high production rate and consumption rate make it a significant 
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source for human exposure even if the potential pathogen load was very small (Painter et al., 2013; 
Wagenaar et al., 2015).  
2.6 Poultry as a Reservoir of Campylobacter 
Poultry and wild birds are a natural host for Campylobacter. The body temperature of the 
chicken is 40-420C—the optimum temperature for C. jejuni replication (Horrocks et al., 2009). 
The primary site of Campylobacter colonization in birds is the ceca, which are a pair of blind 
ended pouches that lay between the ileum and colon in the intestinal tract (Duke, 1986). Within 
the ceca Campylobacter are most frequently found in the mucus layer deep within the cecal crypts 
(Beery et al., 1988; Meade et al., 2009). Campylobacter may preferentially colonize the mucus 
layer due to their chemoattraction to mucin which can act as an energy source (Beery et al., 1988; 
Hugdahl et al., 1988). Campylobacter resides within the bird as a commensal organism—as a part 
of the cecal microbiota (Hermans et al., 2012). Functional genomic analysis of the chicken cecal 
microbiome has suggested that Campylobacter may function as a hydrogen sink to facilitate 
acetate production within its niche environment (Sergeant et al., 2014). Upon infection, the 
immune system of the chicken is poorly activated and studies indicate that Campylobacter down 
regulates the production of antimicrobial peptides of the chicken, both of which enable 
Campylobacter to persist and colonize in high levels within the ceca (Meade et al., 2009; Hermans 
et al., 2011). The density of Campylobacter with the ceca can reach from between 104 to upwards 
of 108 CFU/g of cecal contents (Evans, 1991; Jones et al., 1991; Berndtson et al., 1992; Musgrove 
et al., 2001). As of now there are no available treatments to eliminate Campylobacter from within 




2.6.1 Rates of Contamination on Processed Poultry 
During July 2007 through June of 2008 the USDA FSIS sampled rinsate from young 
chicken carcasses at commercial poultry processing plants. One of the objectives of this survey 
included data analysis to determine a baseline level of Salmonella and Campylobacter on carcasses 
at re-hang and post-chill points within the evisceration process (USDA FSIS, 2008). According to 
their statistics the estimated national prevalence of Campylobacter on post-chill carcasses is 46.7% 
(USDA FSIS, 2008). In addition to the determination of a baseline level of Campylobacter, the 
study also evaluated the effects of interventions used by comparing bacterial levels between re-
hang and post-chill. For Campylobacter, the difference in rates of carcass contamination were 
significantly reduced (from 71.36% to 10.66%) between the two processing points indicating that 
currently implemented interventions had a large effect in reducing Campylobacter contamination 
(USDA FSIS, 2008). 
In the United States the majority of raw retail poultry products are boneless skinless broiler 
meat pieces sold in tray packs (Williams and Oyarzabal, 2012). From January to August of 2012 
the FSIS USDA initiated a new study to compare the levels of Salmonella and Campylobacter on 
whole carcasses at post-chill and then again as raw chicken parts (USDA FSIS, 2012). For this 
analysis the baseline Campylobacter level was adjusted statistically to take into account multiple 
variables including size of the processing establishment (USDA FSIS, 2012). When the young 
chicken baseline study Campylobacter data were adjusted, the adjusted percent positive rate was 
10.6% and that was the number used for calculation. The results of this survey concluded that the 
estimated national prevalence of Campylobacter on raw chicken parts is 21.7% (USDA FSIS, 
2012). When comparing the incidence of carcass contamination to cut up parts, the percentage of 
positive parts is nearly double that of the whole carcass (USDA FSIS, 2012). The FSIS has 
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suggested that the almost doubling of the Campylobacter rate on chicken parts could be due to 
positive carcasses being broken down into multiple parts which can spread the bacterium to 
multiple other pieces of chicken (USDA FSIS, 2012).  
In a study by Scherer and colleagues (2006), investigation into the incidence of 
Campylobacter on chicken skin samples versus internal muscle tissue and found that skin samples 
were 66% positive and internal samples were 27% positive. This is in agreement with an earlier 
studies by Luber and colleagues (2004; 2007) in which they found the greatest levels of 
Campylobacter were on the surface of the meat as compared to internal levels, and skin-on chicken 
products had much higher concentrations of Campylobacter than skin-off parts. When the USDA 
FSIS tested skin-on versus skin-off chicken parts to detect if there was any significant differences 
in Campylobacter levels, they found that skin-on was significantly greater for Campylobacter than 
skin-off (USDA FSIS, 2012). Analysis was also performed on various skin-on chicken parts and 
table 2 lists the percent positive by type of part. Currently there are no USDA FSIS performance 
standards that encompass foodborne pathogens in retail broiler meat. 
 
2.6.2 Contamination in the Processing Plant 
Contamination of chicken carcasses during processing is a function of broilers entering the 
facility with high levels of the bacterium within their intestinal tract as well as on their feathers—
Campylobacter can then spread throughout the processing facility (Keener et al., 2004). As much 
as 90% of broiler chickens in the United States are colonized with Campylobacter, resulting in an 
almost constant influx of the bacterium into the processing plant (Stern et al., 2001). Multiple steps 
during the slaughter and evisceration process can expose the carcass to external contamination.  
2.6.3 First Processing: Slaughter Through Chilling 
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The steps in first processing of poultry include: unloading of the birds and placing them in 
shackles, from there they are stunned and exsanguinated followed by scalding and picking, 
evisceration and finally chilling (Bashor, 2003). 
2.6.4 Cross-Contamination During Processing 
Stern and colleagues (2001) found that during scalding and picking cross-contamination 
can occur possibly from leakage of cloacal contents and the dilation and subsequent contraction of 
the feather follicles which may trap the bacteria. Campylobacter has been isolated from the scald 
water and rubber picker fingers used in the picking process leading to potential sources of 
contamination for subsequent carcasses (Stern et al., 2001). However, an optimized scald tank is 
capable of a 2-3 log10 reduction of the concentration of Campylobacter on carcasses (Oosterom 
and Notermans, 1983; Izat et al., 1988; Berrang et al., 2000). When assessing the potential points 
at which Campylobacter can be introduced into the processing facility and the possibility for 
dissemination the major factors are: 
1) the high concentration of Campylobacter within the alimentary tract (Keener et al., 
2004)  
2) scalding and picking processes, which take place before evisceration, and increase the 
potential for fecal contents being expelled (Stern et al., 2001; Byrd et al., 2005). 
3) the evisceration process itself that can lead to carcass contamination if viscera being 
removed ruptures and spills its contents (Allen et al., 2007; Wagenaar et al., 2015)  
4) the high throughput (upwards of 12,000 to 13,000 birds per hour) and automation 
which creates a system that makes cross-contamination among and between flocks a 




Certain processes that are unique to poultry processing, as opposed to red meat and pork, 
enhance the potential for contamination of the carcass. Factors that promote the cross-
contamination of poultry carcasses include mechanical evisceration, intact skin, and the liberal 
used of water which keeps the carcass and processing environment wet (Butzler and Oosterom, 
1991; Corry and Atabay, 2001).  
2.6.5 The Potential Role of Chicken Skin 
Chicken skin is recognized as an important source for the survival of Campylobacter during 
the multiple stages of processing—including scalding, picking and chilling—leading to cross-
contamination (Wempe and Genigeorgis, 1983; Corry and Atabay, 2001; Stern et al., 2001; Tan et 
al., 2014). Skin and its associated fat is an innate barrier to any environmental animate or inanimate 
object making contact with the underlying tissue—and as such the skin is an excellent site for 
attachment and entrapment of bacteria. Lillard and colleagues (1989) propose that during exposure 
to water (chilling, scalding, rinses) the skin absorbs water—which may already contain fecal 
bacteria—and they loosely attach to the skin by physiochemical bonds. The loosely attached 
bacteria are able to form a biofilm in the thin layer of water covering the surface of the carcass, 
strengthening their attachment and making them much more resistant to being physically removed. 
In addition, microbes can persist in the folds, crevices and feather follicles of the skin as it swells 
with water and become protected from contact with applications of various disinfectants (Corry 
and Atabay, 2001). However, in research trials where direct observation of chicken skin inoculated 
with Campylobacter jejuni and subsequently exposed to sanitizing treatments, the viable 
Campylobacter remained at a higher depth than the feather follicles and crevasses indicating that 
these sites may not play a role in the protection of Campylobacter (Chantarapanont et al., 2004). 
2.6.6 Campylobacter Populations Within Hosts and Environments 
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How is Campylobacter able to survive on the poultry carcass and in the environment of the 
poultry plant—besides protection from the skin? The answer to this is believed to be related to the 
heterogeneous mixture of Campylobacter jejuni strains that exist within their niche environment. 
Researchers have studied the composition of bacterial populations from ‘Farm to Fork’ in an effort 
to trace the points at which specific bacteria are able to pass from live bird to raw retail product 
(Melero et al., 2012). Diverse strains of Campylobacter jejuni colonize the gastrointestinal tract of 
broilers—when following these individual strains through processing the data showed that only 
certain strains can survive (Petersen et al., 2001; Newell et al., 2001; Melero et al., 2012). Strain 
diversity within Campylobacter jejuni potentially enables specific stable or more robust subtypes 
to remain in the processing facility and on the carcass (Newell et al., 2001; Peyrat et al., 2008; El-
Shibiny et al., 2009; Elvers and Morris, 2011; Melero et al., 2012; Duffy et al., 2015). 
2.7 Interventions During First Processing 
Currently in poultry production there are no consistently effective treatments to reduce or 
eliminate Campylobacter from colonizing the birds (Lin, 2009). Due to our inability to prevent 
colonization during grow out, the need for post-harvest methods of pathogen elimination is of the 
utmost importance (Wagenaar et al., 2015). The decontamination process uses the multiple hurdle 
approach—a hurdle being a process in which the goal is to reduce or eliminate unwanted 
microbes—and multiple hurdles used together or sequentially can drastically reduce the bacterial 
load on a food product (Leistner, 2000; Hugas and Tsigarida, 2008; Loretz et al., 2010). Important 
to hurdle methods is the succession of treatments applied to the target product (Geornaras and 
Sofos, 2005; Hugas and Tsigarida, 2008). The importance of reducing the levels of Campylobacter 
on carcasses during processing should not be underestimated–predictive modelling has determined 
that if Campylobacter counts can be reduced by 2 log10 on the carcass the incidence of 
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campylobacteriosis would be reduced 30 fold (Rosenquist and Nielsen, 2003). Methods of 
decontamination for the carcass during processing can be grouped into 3 classifications physical, 
chemical or biological (Hugas and Tsigarida, 2008). Importantly these methods are required to be 
economically feasible, safe and easily implemented into the production scheme, not hazardous to 
wastewater treatment and finally – not result in negative attributes to the final meat product (Loretz 
et al., 2010). 
2.7.1 Physical Treatments 
The goal of physical treatments is removal of fecal contamination and microbial flora of 
the skin on the whole carcass. Physical approaches include but are not limited to water, 
temperature, and radiation treatments.  
2.7.2 Washers 
Water is used copiously during poultry processing. Washing and rinsing of carcasses can 
be accomplished by immersion, spraying and chilling. Since 1978 carcass washing has been 
utilized for removal of gross contaminants on the carcass—and multiple types of washing devices 
have been developed. Common wash systems include brush washers, cabinet washers and 
inside/outside wash cabinets (Conner et al., 2001; Bashor et al., 2004). Depending on the needs of 
the plant, multiple washer systems can be used throughout the processing work flow. To the water 
in these washer devices chemical treatments may be added (most commonly chlorine) and the 
pressure of the water as it contacts the carcass can be adjusted. The pressure is important as a 
balance must be made between too high, which can force bacteria into the skin, and low enough 
to allow for removal of organic material on the carcass (Conner et al., 2001). Overall the effect of 
carcass washing is shown to reduce the bacteria on the carcass by 1 -3 log10 (Hugas and Tsigarida, 




Chilling systems are used to reduce the temperature of the broiler carcass after first 
processing from body temperature to 40C or lower within 4 hours (Sams, 2001). Most commonly 
in the United States immersion style chillers are used, however air-dry systems and evaporative 
air chillers are also available (El-Shibiny et al., 2009). The goal of carcass chilling is to reduce the 
growth of microbes on the surface of the carcass for both food safety and shelf-life considerations 
(Sams, 2001). Interestingly, research has demonstrated that Campylobacter populations on the skin 
of the carcasses can be resistant to inactivation by chilling depending upon the conditions in which 
the carcass was frozen—and some research demonstrated increased survivability of 
Campylobacter from super-chilling treatments and storage at 40C (Zhao and Ezeike, 2003; El-
Shibiny et al., 2009; Ivić-Kolevska et al., 2012). 
2.7.4 Irradiation 
Irradiation is a poorly accepted yet highly effective means by which pathogenic bacteria, 
including Salmonella spp. and Campylobacter spp. can be inactivated on the surface of the carcass 
or meat products (MacRitchie et al., 2014; Wagenaar et al., 2015). Gamma and X-ray irradiation 
treatments expose the surface matrix to ionizing radiant energy that damages the DNA of the 
microbe rendering it unable to survive and multiply (CDC, 2005). The investigation into the 
utilization of irradiation—more specifically gamma irradiation—of poultry products contaminated 
with Campylobacter has determined the dose at which 90% of the bacterium are killed is between 
0.12 and 0.31 kGy—dependent upon the packaging of the product and strain of Campylobacter 
(Lambert and Maxcy, 1984; Patterson, 1995; Kudra et al., 2012; Raut et al., 2012). In the early 
1990’s the FDA and USDA approved the use of 1.5 to 3 kGy on fresh or frozen raw packaged 
poultry products (USDA, 1999; CDC, 2005). 
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2.7.5 Processing Aids 
During first processing most if not all large poultry processors supplement their physical 
interventions with processing aids. As defined in the FDA CFR 21 CFR 101.100 processing aids 
are:  
1. Substances that are added to a food during the processing of such food but are 
removed in some manner from the food before it is packaged in its finished form. 
2. Substances that are added to a food during processing, are converted into 
constituents normally present in the food, and do not significantly increase the 
amount of the constituents naturally found in the food. 
3. Substances that are added to a food for their technical or functional effect in the 
processing but are present in the finished food at insignificant levels and do not 
have any technical or functional effect in that food (FDA, 2014). 
 
Antimicrobial compounds utilized during poultry processing to reduce foodborne 
pathogens on the surface of meat are classified as processing aids (National Chicken Council,). 
These compounds are approved by the FDA and USDA and many are listed as Generally 
Recognized as Safe (GRAS). The three primary classes of chemical processing aids are chlorine 
compounds, phosphate based compounds and organic acids (Hugas and Tsigarida, 2008; Loretz et 
al., 2010; Wagenaar et al., 2015). In a survey of U.S. commercial poultry operations, peracetic 
acid (PAA) was the leading chemical intervention and used with less frequency was cetylpyridium 
chloride (CPC), chlorine, acidified sodium chloride (ASC) and acids with a pH of 2.0 (McKee, 
2011). USDA FSIS provides specific information on acceptable levels of permitted compounds in 
the FSIS directive 7120.1—listing approved substance levels within the mode that they are used 
in the processing plant (USDA FSIS, 2015). 
2.8 Chlorine Based Compounds 
2.8.1 Sodium Hypochlorite (Chlorine) 
Historically chlorine has been the most frequently used chemical in poultry operations, 
with the benefits of being readily available and low cost. It can be added to processing water in 
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either a gas form or as the liquid sodium hypochlorite (Keener et al., 2004). The USDA has set the 
allowable levels; 20 ppm in bird washers, 50 ppm in potable water to be used in the primary chillers 
and 5 ppm in the recycled water used in the pre-chiller (USDA FSIS, 2015). In practice the 
antimicrobial effectiveness of chlorine—as used in poultry processing—has limited efficacy due 
to its dependence on pH of the water, long contact time and inactivation by organic material present 
in the water (Keener et al., 2004; Oyarzabal, 2005). When specifically investigating 
Campylobacter levels on poultry in relation to the age of the chiller water Yang and colleagues 
(Yang et al., 2001) found that chiller water with 10 ppm chlorine had a 3.3 log CFU/mL reduction 
when fresh but at 8 hours the reduction was less than 0.5 CFU/mL. 
2.8.2 Chlorine Dioxide 
Chlorine dioxide is also acceptable to be added to water used in poultry processing—it has 
advantages of being a more stable compound and a more effective bactericidal agent in the 
presence of organic matter—with less impact on organoleptic qualities of the meat (Conner et al., 
2001). It is allowed to be used at up to 3 ppm in water that has direct contact with whole fresh 
poultry carcasses (USDA FSIS, 2015). Comparisons of chlorine to chlorine dioxide indicate that 
chlorine dioxide is effective at lower concentrations and has up to 7 times more activity than 
chlorine (Lillard, 1979). Campylobacter cells are susceptible to injury from chlorine dioxide and 
it is reported that up to 97% of C. jejuni cells became injured when exposed to 20 ppm for 2 
minutes (Smigic and Rajkovic, 2011). 
2.8.3 Acidified Sodium Chlorite (ASC) 
Acidified sodium chlorite as used in the poultry processing plant is a mixture of sodium 
chlorite and citric acid and works as a broad spectrum oxidative antimicrobial. It can be applied 
by either spraying or dipping during pre-chill, chill and/or post-chill processes. Work by Orzybal 
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and colleagues (2004) demonstrated that a post-chill application of ASC significantly reduced 
Campylobacter to less than 0.2 log CFU/mL.  
2.8.4 Organic Acids Used as Interventions 
Organic acids can be added as part of an intervention plan to reduce microbial counts on 
poultry carcasses. They have the benefit of being more stable in the presence of organic material. 
The FSIS directive states that the organic acids can be applied as a small droplet rinse, fog or a 
mist at aqueous concentrations up to 2.5% (USDA FSIS, 2015). Organic acids including acetic 
acid, lactic acid, citric acid and succinic acid have demonstrated antimicrobial activity when used 
in poultry processing—however care must be used when applying these acids due to their negative 
effects on the sensory characteristics of the poultry meat (Blankenship et al., 1990; Bilgili and 
Conner, 1998; Keener et al., 2004). Overall, the general efficacy of organic acids is variable and 
results depend upon contact time, concentration and the temperature at the time of application 
(Dickson and Anderson, 1992). The addition of 0.1% acetic acid to scald water was able to reduce 
Campylobacter levels by 1.5 log10 CFU/mL—when added directly to chicken wings a 1% lactic 
acid treatment was found to be less effective than 0.5, 1.0, 1.5 and 2.0% acid concentrations 
(Okrend et al., 1986; Zhao and Doyle, 2006). When acetic acid (2%) and lactic acid (3%) were 
used in combination to treat the surface of leg and breast samples the concentration of 
Campylobacter was reduced by 0.36 – 1.98 log10 CFU/cm2 when compared to treatment with a 
water control (Coşansu and Ayhan, 2010).  
2.9 Phosphate Based Compounds 
2.9.1 Trisodium Phosphate (TSP) 
The USDA has declared trisodium phosphate to be a GRAS compound approved for use 
during pre-chill and post-chill poultry processing at 8–12% (USDA FSIS, 2015). Trisodium 
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phosphate has several characteristics that make it a beneficial compound in regards to food safety. 
It is reported to be more effective at reducing Gram negative bacteria including the pathogens 
Salmonella, E.coli and Campylobacter (Bashor et al., 2004; Keener et al., 2004). It is theorized 
that the mechanisms involved in bacterial reductions on the surface of carcasses treated with TSP 
are caused by: the high pH (9–11 at 12%) which disrupts the bacterial cell membranes in addition 
to the removal of a negligible amount of surface fat that helps remove loosely attached bacteria 
during washing (Keener et al., 2004). Evaluation of a post-chill application of 10% TSP on poultry 
carcasses and subsequent analysis of Campylobacter levels at 0, 1 or 6 days revealed a significant 
decrease in levels at both 1 and 6 days (Slavik et al., 1994). Pre-chill applications of TSP, while 
effective, can have a negative impact on the treatment effect of the compound used in the chill 
tank. TSP is a highly basic compound with a pH of 11.8 at a 12% solution—introduction of TSP 
into chiller water from the surface of treated carcasses can increase the pH to levels which prevent 
the antimicrobial activity of chlorine compounds (Keener et al., 2004). 
2.9.2 Peracetic Acid (PAA) 
Peracetic acid is produced as a mixture of acetic acid and hydrogen peroxide in water and 
is a strong oxidizer and acid—in contact with cell membranes it disrupts permeability and 
interferes with protein synthesis (Baldry and Fraser, 1988; Wideman, 2013). It has been widely 
used in the food industry starting in the 1950’s when it was applied as a fungicide and antimicrobial 
on fruits and vegetables, however it was not until 2001 that PAA was legally permitted to treat 
poultry carcasses and parts (FDA, 2013a). The antimicrobial activity of peracetic acid is dependent 
upon the pH and temperature at which it is used. In accordance with the FSIS Directive 7120.1 the 
allowable upper limit of peracetic acid and hydrogen peroxide in the chiller is 220 ppm and 110 
ppm respectively—when used as a post-chill dip solution the allowable concentration is 2000 ppm 
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(USDA FSIS, 2015). The three stages of first processing at which PAA is most frequently utilized 
is (1) on pre-chill carcasses (2) during chilling and (3) as a post-chill dip or spray (EFSA BIOHAZ 
Panel, 2014). When PAA was evaluated against chlorine in a commercial setting as applied during 
chilling the overall percentage of Campylobacter positive carcasses decreased by 43% as 
compared to the chlorine control (Bauermeister et al., 2008).  
2.9.3 Cetylpyridinium Chloride (CPC) 
Cetylpyridinium chloride is a cationic quaternary ammonium compound and is most 
commonly found in mouthwash and throat lozenges. Its application in poultry processing can be 
at pre-chill, post-chill or as a pre-package intervention. It is allowed by USDA to be applied at 
concentrations of up to 0.8% (USDA FSIS, 2015). CPC is able to interact with negatively charged 
molecules on the surface of bacteria which leads to cellular leakage, interference with cellular 
metabolism and ultimately cell death (Scheie, 1989; Smith et al., 1991). Trials with CPC have 
demonstrated that at 0.5% it is highly effective against Campylobacter. Waldroup and colleagues 
(2000) reduced Campylobacter to non-detectable levels with 10 second dip in 0.5% CPC and Cargi 
and co-workers (2004) found a 99.7% reduction also with a 0.5% solution. 
2.10 Post-Harvest Treatment of Raw Ready to Eat Poultry Products 
2.10.1 Antimicrobial Edible Coatings 
The use of coating treatments on raw poultry products can be considered another 
intervention to add to the multiple hurdle approach for enhancing the food safety of poultry 
products (Ricke and Hanning, 2013). The concept of coating a food item in order to keep it fresh 
longer (inhibition of spoilage microorganisms) dates back hundreds of years to practices in Asia—
in 12th century China wax coatings were applied to fruits to slow water loss, and in Japan during 
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the 15th century the first edible food coating was developed from soymilk (Hardenburg, 1967; 
Gennadios et al., 1993).  
In use today are edible coatings prepared from various substances including protein, 
polysaccharides and lipids. The food grade substances are made into a solution which may then be 
sprayed, dipped or spread onto the surface of the food matrix and allowed to dry into a transparent 
layer; this coating is defined as part of the final product (McHugh, 2000; Han and Gennadios, 
2005; Falguera et al., 2011). To enhance the functionality of the coating treatment antimicrobial 
substances can be integrated into it to deliver another layer of food safety (Sánchez-Ortega, 2014). 
Edible coatings with antimicrobial activity can add value to food commodities while improving 
food safety—in addition these coatings and antimicrobials are being developed from natural 
materials including chitin, fatty acids and essential oils in place of chemical preservatives—which 
is favorable to consumers (Gennadios et al., 1997; Salleh et al., 2007; Sánchez-Ortega, 2014). 
2.10.2 Generally Recognized as Safe (GRAS) Designation 
Due to the fact that edible coatings are physically added to the food product and there is no 
expectation of the coating to be removed before consumption it is considered a food additive; it is 
important that the coating and any antimicrobials added to it are made from food-safe materials, 
most frequently with FDA approved Generally Recognized As Safe (GRAS) designated 
constituents (FDA, 2015). The use of GRAS labelled compounds as food additives does not require 
a premarket review and FDA approval. Food additives can be grouped into 1 of 3 different GRAS 
categories: 
(1) Self-affirmed, where the manufacturer has carried out necessary work and is ready to 
defend GRAS status if challenged, 
(2) FDA pending, where results of research have been submitted to FDA for approval, and  
(3) No comment- which is the response of FDA if after review, it has no challenges 




However, it is essential to understand that if the material is designated as GRAS by FDA it does 
not provide a guarantee of absolute food safety (Pavlath and Orts, 2009). 
2.11.1 Chemical and Physical Characteristics of Chitosan 
In the area of edible and antimicrobial food coatings, chitosan (derived from chitin) is a 
polymer that has received a great amount of interest due to its numerous favorable attributes (Dutta 
et al., 2012). Published reports list the positive aspects of chitosan based coatings include (1) non-
toxic and non-polluting, (2) possessing antimicrobial/antifungal activity, (3) low cost and 
abundance of source material (4) edibility (5) biodegradable, (6) positive chemical properties for 
ease of industrial use (Kong et al., 2010; Aider, 2010; Sánchez-González et al., 2011; Elsabee and 
Abdou, 2013). Chitosan is currently used in food industries outside of the U.S. as a coating, it has 
been approved since 1983 in Japan and is also approved for use in Canada—while it currently does 
not have FDA GRAS status it is expected that it will receive approval in the near future (Baldwin, 
2007; Vasilatos and Savvaidis, 2013; Zivanovic et al., 2014). Chitin was first discovered in the 
early 1800’s due to its unusual stability when exposed to common acids and subsequently received 
a name derived from the Greek ‘chiton’ meaning a coat of mail (Lower, 1984; Jeuniaux, 1996). 
Chitin soon came to be recognized as the major component of the exoskeletons of arthropods and 
is also found in fungi, mushrooms, and worms (Arcidiacono and Kaplan, 1992; Khoushab and 
Yamabhai, 2010). Chitosan is produced by the removal of an acetyl group from the original chitin 
molecule in the presence of sodium hydroxide. In the marketplace chitosan is characterized by its 
degree of deacetylation and average molecular weight; both of which have direct impacts on its 
functional qualities (No and Meyers, 1995; Cho et al., 1998; Elsabee and Abdou, 2013). 
 
Chitosan is a highly versatile biopolymer and is one of the most abundant in nature (second 
only to cellulose)—estimates are that 1011 tons of chitin is produced globally each year by natural 
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processes and industrial use of chitin is approximately 10,000 tons per year (Muzzarelli et al., 
1986; Arcidiacono and Kaplan, 1992; Kim, 2010). The crab and shrimp industry generates the 
greatest amount of chitosan as a byproduct of processing and due to the extended amount of time 
required for it to degrade the accumulation of shellfish waste is a significant concern of the 
shellfish industry and so finding a use for this byproduct is very helpful (Shahidi and Synowiecki, 
1991). 
 
2.11.2 Antimicrobial Activity of Chitosan 
The antimicrobial mode of action for chitosan is still under investigation, but there is 
consensus that its activity is directly related to the degree of deacetylation, the molecular weight, 
concentration in solution, pH of the chitosan solution, temperature and food matrix in which the 
chitosan is applied (Dutta et al., 2009; Aider, 2010; Elsabee and Abdou, 2013). The theorized 
mechanisms of action include: interaction of the positively charged amino group of the chitosan 
disrupting the negatively charged cell membrane which will lead to leaking of cellular contents 
(Young et al., 1982; Shahidi et al., 1999; Kim and Thomas, 2003), chitosan may stimulate the 
production of chitinases and other defense proteins in host cells (Ghaouth et al., 1992), chitosan is 
able to chelate trace metals leading to inhibition of microbial growth (Cuero et al., 1991) and lastly, 
if chitosan penetrates the cell wall it disrupts protein synthesis by binding to host DNA (Sudarshan 
et al., 1992). It is reported in the literature that the more highly deacetylated chitosan has a greater 
antimicrobial effect and, in addition, the lower the pH of the chitosan the more effective it is 
(Sekiguchi et al., 1993; Dutta et al., 2009). More specifically, Zheng and colleagues (Zheng and 
Zhu, 2003) investigated the differing antimicrobial mechanisms of chitosan against Gram-positive 
and Gram-negative bacteria and concluded that as the molecular weight of chitosan increased it 
was more bactericidal towards Gram-positives and the direct opposite was true for Gram-negative 
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organisms. It is their theory that for Gram-positive bacterial the chitosan forms a barrier that block 
nutrients from entering the cell and for the Gram-negative organism chitosan enters the cell and 
disrupts normal cellular functions. The utilization of chitosan to inhibit the growth of foodborne 
disease causing bacteria has received a great amount of attention and chitosan has been shown to 
be very effective against S. aureus, E.coli, non-typhoidal Salmonella, Listeria spp., Vibrio spp., B. 
cereus and Campylobacter spp. (Chhabra et al., 2006; Beverlya et al., 2008; Ganan, 2009; 
Friedman and Juneja, 2010). Research into the application of chitosan onto raw chicken skin has 
produced positive results—Menconi and colleagues (2013) were able to reduce Salmonella 
Typhimurium and extend the shelf-life of skin treated with a 0.5% chitosan solution, thus 
demonstrating the role for chitosan in enhancing food safety and improving quality. In addition to 
studies on planktonic cells, chitosan and its derivatives were tested on mature biofilms of Listeria 
monocytogenes and Salmonella enterica and produced significant reductions in the attached 
populations of the pathogens (Orgaz et al., 2011).  
2.11.3 Chitosan Coating of Poultry Products 
Research and development into the utilization of chitosan in the food industry is directly 
related to the increase in consumer interest for fresh, microbiologically safer, minimally processed 
food products—and chitosan films and coating are especially useful because of their antimicrobial 
and antifungal properties plus their functional capabilities as carriers of other inhibitory 
compounds, including spices, organic acids, essential oils, and nutraceuticals (Ouattara et al., 
1997; Appendini and Hotchkiss, 2002; Tapia and Rojas Graü, 2007; Petrou et al., 2012; Vasilatos 
and Savvaidis, 2013; Fernández-Pan et al., 2014). Many natural compounds including plant 
derived antimicrobials and essential oils are themselves inhibitory to foodborne pathogens, 
however to obtain maximum effect high concentrations are sometimes needed, potentially 
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affecting organoleptic properties of the food (Ntzimani et al., 2011; Sánchez-González et al., 2011; 
Petrou et al., 2012). There is much interest in the combination of chitosan and these natural 
compounds—to reduce the concentrations of natural compounds necessary for efficacy and to 
evaluate potential synergism (Elsabee and Abdou, 2013). The use of chitosan and its incorporation 
with natural compounds for the treatment of poultry products to extend shelf-life and reduce 
pathogens has generated much positive data. Petrou and colleagues (2012) successfully extended 
the shelf-life of MAP packaged chicken breast fillets by 6–12 days with the application of 1.5% 
chitosan or 1.5% chitosan plus oregano oil. The combination of chitosan and thyme essential oil 
was able to significantly reduce spoilage organisms, Enterobacteriacae and lactic acid bacteria on 
packaged chicken kebabs after 12 days of storage as compared to the controls (Giatrakou et al., 
2010). Ready-to-eat products are an especially important product for the control of foodborne 
pathogens. When chitosan and mixtures of chitosan plus lauric arginate or nisin were applied to 
turkey deli meat Listeria innocua was reduced by up to 4 log CFU/cm2 (Guo et al., 2014). 
Similarly, Zheng and co-workers (2011) significantly reduced Listeria monocytogenes on roasted 
turkey meat by treatment with chitosan coatings incorporated with sodium lactate or sodium 
diacetate. The liquid purge that accumulates in the packaging of raw poultry products is another 
potential source for microbial growth of spoilage organisms and pathogens. The treatment of 
chicken purge, artificially inoculated with E. coli, by a chitosan-arginine solution was able to 
reduce both the actual microbial counts and the metabolic activity of E.coli (Lahmer et al., 2012).  
2.12 Caprylic Acid in the Food Industry 
The increased consumer preference for less chemically treated foods has turned more 
attention to plant derived antimicrobials as an alternative. It has been reported that the possible 
benefits for the use of antimicrobials derived from plants instead of organic chemicals include lack 
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of inciting bacterial resistance and less potential for negative environmental effects (Wyk and 
Gericke, 2000; Ohno et al., 2003; Ali et al., 2005; EFSA BIOHAZ Panel, 2014). Caprylic acid—
a medium chain fatty acid found in breast milk, cow milk, palm kernel oil and coconut oil—has 
many positive characteristics for its use as a decontaminant on edible products (Jensen and Ferris, 
1990; Sprong et al., 2001; Al Shahib and Marshall, 2003). Caprylic acid has reported broad 
spectrum antibacterial activity, and specific activity against the foodborne illness causing 
organisms Listeria monocytogenes, E.coli O157:H7, Staphylococcus aureus, Salmonella spp. and 
Campylobacter spp. (Kabara et al., 1972; Wang and Johnson, 1992; McLay et al., 2002; Nair and 
Vasudevan, 2004; Skrivanova, 2007). 
2.12.1 Guidelines for Use of Caprylic Acid in Food Processing 
The FDA (21CFR184.1025) has designated caprylic acid as a GRAS multipurpose food 
ingredient—the maximum acceptable levels for its inclusion in foods is up to 10 mg/kg and in 
snack foods the tolerance is up to 160 mg/kg (FDA, 2014). It is also approved by EPA as an 
antimicrobial pesticide—it is approved for use as a sanitizer to kill or inhibit microbial growth on 
inanimate objects in commercial kitchens, health care facilities, dairy and food processing plants 
(EPA, 2014). The toxicity of caprylic acid is very low, the EPA lists the oral LD50 (in rats) as a 
range of 1283 mg/kg to 10,080mg/kg of bodyweight and the dermal LD50 (in rabbits) is greater 
than 5000 mg/kg; in addition when supplemented at levels up to 50% of dietary fat in a balanced 
diet no toxic effects were observed (Traul et al., 2000; EPA, 2014). 
2.12.2 Proposed Mechanisms of Action for Fatty Acids 
Fatty acids from animal and vegetable sources have been used for thousands of years in 
soap making and it is the type and amount of fatty acids that determine the physical properties of 
the soap (Oghome et al., 2012). Today bar soap is generally 80% mixed carrier oils and 
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approximately 20% coconut oil; which is a natural source for saturated medium chain fatty acids 
(including caprylic acid) and are valued for their efficient removal of dirt and the production of 
foamy lather (Oghome et al., 2012). Several mechanisms have been proposed for the antimicrobial 
properties of fatty acids most of which are related to the aliphatic nature of saturated fatty acids 
and their ability to interact with cell membranes (Freese et al., 1973). Included in the potential 
mechanisms of action are (1) the creation of pores in the cell membrane (Petschow et al., 1996) 
(2) the diffusion of fatty acids into the cell resulting in a lowered intracellular pH that interferes 
with energy transport (Gauthier, 2002; Sun et al., 2002) (3) the inhibition of cellular glycolysis 
(Brul and Coote, 1999). As a consequence of fatty acids having many potential mechanisms for 
killing or inhibiting microbial growth, the selection for resistance within the microbial community 
is not likely to occur (Lacey and Lord, 1981; Petschow et al., 1996; Sun, 2003) 
2.12.3 Fatty Acid Treatment of Poultry Skin 
The application of fatty acids or their salts to reduce foodborne pathogens on chicken 
carcasses and skin has demonstrated the potential for these natural molecules to serve as part of 
the scheme of reducing foodborne illness from poultry. During in-vitro testing, Campylobacter 
was found to be particularly susceptible to capric acid (C10) and its derivative monocaprin when 
exposed in a slightly acidic medium, a pH 4-5 (Thormar, 2006). In a follow up study, Thormar and 
colleagues (2006) created a stable emulsion of the monocaprin and applied it to chicken legs and 
neck skins; there were significant log reductions in the recovery of Campylobacter from the treated 
legs (1.6-2.58 log) and neck skin (1.89-3.04 log) as compared to a treatment with water or samples 
left untreated. Oleic acid, when applied to poultry skin, was able to reduce Campylobacter 
significantly, and in addition, it reduced the total amount of aerobic bacteria attached to the skin 
surface (Hinton and Ingram, 2000).  
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Limited research on the use of caprylic acid or it derivatives as a treatment for the 
decontamination of chicken skin to reduce foodborne illness has shown promising results. 
Treatment of chicken skin and meat with a 5.0% concentration of caprylic acid sodium salt 
produced significant reductions in Campylobacter counts by up to 2.84 log10 on skin and 4 log10 
on meat after treatment and storage at 40C for 24 hours (Riedel and Brøndsted, 2009). On chicken 
skin artificially contaminated with Salmonella spp., the application of 0.75 mg/mL of caprylic acid 
significantly reduced the amount of recoverable Salmonella at days 1, 2, and 3 as compared to a 
saline control treatment (Skřivanová et al., 2012). 
2.13 Introduction to Lactic Acid Bacteria 
The utilization of bacteria by humans for the processing of foods is thousands of years 
old—bacterial fermentation to produce sourdough bread and dairy products including butter, 
yogurt and cheese has been discovered in cultures that date back as far as 5000 years ago (Währen, 
1990). Interest in bacteria that produce lactic acid (and provide us fermented foods) has been 
ongoing since the mid 1850’s when Pasteur studied the process of lactic acid fermentation and 
Lister became the first person to document the isolation of a pure bacterial culture (Bacterium 
lactis) in 1873 (Lister, 1873; Stiles and Holzapfel, 1997). The use of lactic acid bacteria for the 
industrialized production of fermented food was started in 1890 in Copenhagen and is still in use 
today (Stiles and Holzapfel, 1997). It was in the early 1900’s that the first pioneers in microbiology 
conceived of the idea to classify these lactic acid producing bacteria in a group they called lactic 
acid bacteria (LAB) (Orla-Jensen, 1919). This group was composed of gram-positive, non-motile, 
non-sporeforming, rod or coccus shaped bacterium which are able to grow in microaerophilic to 
strict anaerobic conditions and which produce mainly lactic acid as their end product during 
fermentation of carbohydrates (Orla-Jensen, 1919; Stiles and Holzapfel, 1997). The interest in 
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these organisms for their possible healthful properties to humans was pioneered by Elie 
Metchnikoff while at the Pasteur Institute, he believed that this group of bacteria could help prevent 
and treat illness from harmful bacteria and prolong the duration of a persons life (Metchnikoff, 
1907; Bibel, 1988). 
2.13.1 Lactic Acid Bacteria as Probiotics 
Today these lactic acid bacteria are most frequently associated with probiotics. The 
definition of probiotic—from the Greek, meaning for life—has gone through many iterations since 
it was first introduced in 1965 (Lilly and Stillwell, 1965). According to the International Scientific 
Association for Probiotics and Prebiotics the agreed upon consensus for the definition of probiotic 
is: 
‘Live microorganisms that, when administered in adequate amounts, confer a health 
benefit on the host.’ (Hill et al., 2014) 
Lactic acid bacteria most commonly used as commercial probiotics include Lactobacillus, 
Bifidobacterium, and Streptococcus (Hamilton-Miller, 1997; Stiles and Holzapfel, 1997; Klein et 
al., 1998; Naidu et al., 1999). It is agreed upon that probiotic cultures must be safe within the 
conditions of their use and while there is no 100% certainty for the potential of adverse effects 
many of these strains have a long history of use without significant associations with pathogenicity 
within normal healthy populations (Saxelin and Chuang, 1996; Hamilton-Miller, 1997; Boyle et 
al., 2006; Ljungh and Wadstrom, 2006; Vankerckhoven and Huys, 2008; Sanders, 2009). 
2.13.2 Antimicrobial Activity of Lactic Acid Bacteria 
Probiotic lactic acid bacterial strains are reported to produce a diverse variety of activity to 
promote health, which can be broadly grouped into nutritional, physiological and antimicrobial 
activity (Naidu et al., 1999). Investigation into the many mechanisms by which lactic acid bacteria 
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are capable of inhibiting or killing other bacteria, including food-borne pathogens, has 
demonstrated the production of: (1) short chain fatty acids (SCFA) including acetic, lactic and 
proprionic acid, (2) production of hydrogen peroxide in anaerobic conditions and (3) production 
of specific inhibitory molecules (bacteriocins) (Havenaar et al., 1992; Sanders, 1993; Gibson et 
al., 1997; Robyn et al., 2015). In addition to the production of inhibitory substances and molecules 
other mechanisms have been proposed including competition for nutrients, attachment sites and 
the interference with pathogenic mechanisms of Enterbacteriaceae (Havenaar et al., 1992; 
Sanders, 1993; Saavedra, 1995; Naidu et al., 1999). It is important to understand that the 
mechanisms of antibacterial activity and production of inhibitory substance are strain specific and 
strains should be characterized on an individual basis to determine if they have probiotic traits 
(Ljungh and Wadstrom, 2006).  
 
2.13.3 Use of Probiotics in Poultry Production 
The administration of probiotic bacteria to broilers and turkeys is a common practice and 
there are many commercially available direct fed microbials available on the market. Probiotics 
are provided to poultry for the main objectives of promoting gut health, prevention of disease 
related to environmental stress of the bird, and for the promotion of performance characteristics 
important to the commercial poultry industry (Davis and Anderson, 2002; Talebi et al., 2008; 
Wideman et al., 2012; Neal-McKinney et al., 2012; Huff et al., 2015). Interest in probiotics is 
continually increasing—mainly due to consumer and regulatory pressure for the discontinuation 
of antibiotic growth promoters and the increasing demand for antibiotic free poultry meat (FDA, 
2012, 2013b; Kesmodel et al., 2014). Commercial poultry companies and allied health industries 
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are interested in the potential for probiotic bacterial strains to replace antibiotic growth promoters 
in the poultry industry. 
2.13.4 Probiotics to Prevent Campylobacter Infection in Pre-harvest Poultry 
It is well documented that within the chicken the greatest numbers of Campylobacter spp. 
inhabit the cecum and thrive within the cecal crypts—chemoattraction to mucin within this 
environment supplies the bacteria with energy (Beery et al., 1988; Hugdahl et al., 1988; 
Meinersmann et al., 1991; Achen et al., 1998; Van Deun et al., 2008). There is much literature on 
the proposed idea of isolating LAB strains which (1) produce anti-Campylobacter metabolites 
and (2) can competitively inhibit Campylobacter within its niche environment (Nurmi and 
Rantala, 1973; Schoeni and Doyle, 1992; Gaggia et al., 2011). By preventing Campylobacter 
from colonizing within the bird, the downstream effects would be the reduction of foodborne 
illness from contaminated poultry meat (Andreoletti et al., 2011). Many studies have 
demonstrated that it is possible to isolate—from chickens or other species—strains of LAB that 
produce substances which are inhibitory to Campylobacter in-vitro (Chaveerach et al., 2004; 
Stern and Svetoch, 2006; Zhang et al., 2007; Bhaskaran et al., 2011; Ganan et al., 2013; Cean et 
al., 2015). The administration of these LAB strains to broiler chickens have been evaluated for 
their ability to reduce Campylobacter within the birds gastrointestinal tract, Aguiar and 
colleagues (2013) were able to produce a reduction in the colonization of broiler chickens by 
administration of motility enhanced probiotic isolates and Neal-McKinney and colleagues (2012) 
also decreased Campylobacter in broiler chicks with strains of Lactobacillus evaluated for their 
in-vitro production of lactic acid. Additionally, researchers have evaluated methods to increase 
the efficacy of specific LAB with in-vivo anti-Campylobacter activity by the addition of 
fructooligosaccharide or mannan oligosaccharide as a prebiotic treatment in feed.  Arsi and 
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colleagues (2015a) demonstrated that the addition of 0.04% mannan oligosaccharide in the feed 
in combination with an isolate of Lactobacillus salivarius reduced Campylobacter counts in the 
ceca by 3 logs as compared to the control. Frequently, in trials which involve the testing of LAB 
isolates with in-vitro inhibitory activity in live birds by oral administration of the cultures there is 
a failure to see reductions in Campylobacter levels within the gastrointestinal tract. A recently 
proposed model to more efficiently assess the antimicrobial effects of specific LAB cultures 
within the cecal environment has demonstrated that intra-cloacal inoculation of LAB isolates was 
more specific at determining in-vivo efficacy than oral administration as a screening tool (Arsi et 
al., 2015b). 
In addition to the antimicrobial activity of the lactic acid produced by LAB, many 
researchers have investigated the production of bacteriocins specific to killing Campylobacter 
and evaluated their ability to be administered to poultry as either a therapeutic or prophylactic 
treatment to suppress or eliminate Campylobacter infection. Trials involving purification, 
characterization and ultimately dosing of broiler chickens with anti-Campylobacter bacteriocins 
has demonstrated these molecules are highly effective at reducing Campylobacter in-vivo (Stern 
and Svetoch, 2006; Line and Svetoch, 2008; Svetoch and Eruslanov, 2008; Stern et al., 2009; 
Svetoch and Stern, 2010). However, when performing a survey of the literature regarding the use 
of probiotics in poultry the general trend is toward a wide degree of variability of results—
factors that influence the variability include the strain of bacterium used, its proposed mechanism 
of action, how it interacts with the host and the environment in which it ultimately settles within 




2.13.5 Application of Lactic Acid Bacterial Cultures to Raw Meat Product 
The application of lactic acid bacteria—to perform as a protective culture or biological 
preservative—on the surface of poultry carcasses or raw retail product may be another hurdle 
that could be added to the food safety programs currently in use (Holzapfel et al., 1995). The 
concept of biological preservation may not be a term readily encountered but it is a technique 
that has been used for thousands of years—specifically to make fermented foods and beverages 
(Stiles, 1996). While we may not accept the idea of fermentation in the context of our raw 
poultry products the application of bacterial cultures onto meat may provide several advantages: 
(1) live organisms may produce metabolites which are inhibitory to other spoilage bacteria, 
leading to increased shelf-life of the product (2) and/or the production of substance inhibitory to 
pathogenic microorganisms which may increase the food safety aspect of the product (3) there 
may be potential health benefits to the consumer by ingestion of the added probiotic culture (4) 
biopreservation with natural lactic acid bacterial cultures might be a more acceptable treatment 
for edible products, as compared chemical treatments by consumers (Holzapfel et al., 1995; 
Schillinger et al., 1996; Stiles, 1996; Gálvez et al., 2010; Garcia et al., 2010; Gaggia et al., 2011). 
In an opinion by Maragkoudakis and colleagues (2009) the use of lactic acid bacteria as a 
protective culture on poultry meat is a feasible and safe option due to their ubiquitous nature in 
the foods we already consume, they have been identified as a constituent of normal flora in the 
human gut microbiome and these organisms have essentially been a part of our diet for 




Currently there is no official opinion or guideline from our government in regards to 
protective cultures—however the strains of bacteria that could potentially be used in this manner 
share many attributes with probiotic bacterial strains, and so guidelines in place for probiotics 
may be useful to developers of protective cultures. Due to the increased interest world-wide in 
the development and use of probiotic cultures in foods, the World Health Organization together 
with the Food and Agriculture Organization of the United Nations has proposed guidelines on 
the selection of probiotic cultures (FAO, WHO, 2006). It is the intent of the guidelines to help 
researchers and the food industry to provide to consumers probiotic cultures, as related to food 
items, which provide consistent results, are well characterized and safe for human consumption. 
Research trials involving the application of live protective cultures onto raw poultry meat 
surfaces for the reduction of the foodborne pathogen Campylobacter are sparse. There is 
literature, however, on application of live protective cultures to reduce Salmonella spp. and 
Listeria spp. in raw poultry meat. In a study by Maragkoudakis and colleagues (2009) they 
surveyed 635 lactic acid bacterial cultures for their potential to act as protective cultures, 
displaying antagonistic activity against Listeria monocytogenes and Salmonella enteritidis 
specifically, in chicken meat. After performing in-vitro tests on the 635 isolates, which included 
screening for antibiotic resistance profiles, the presence of bacteriocin producing genes and 
survivability within food processing and gastrointestinal tract environments, 2 strains were 
selected for further testing on the chicken meat itself. The results demonstrated that the two 
cultures, E. faecium and L. fermentum were able to decrease the total population of both 
pathogens by what they speculate is not a direct killing effect but an inhibition of the growth rate 
of the pathogens and in addition, the application of these bacterial strains did not produce 
detrimental effects in regards to spoilage of the meat. In a more recent trial Sakaridis and 
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colleagues (2014) tested the application of lactic acid bacteria against Salmonella spp. and 
Listeria spp. on chicken skin and meat. The application of L. salivarius to chicken skin that was 
inoculated with either Salmonella spp. or Listeria spp. produced a significant, but modest, 
reduction in the amount of pathogen remaining on the skin after 7 days. The log reduction in 
Salmonella spp. was 0.54 log CFU/cm2 and for Listeria spp. was 0.71 log CFU/cm2 at the day 7 
time point. Trials involving chicken meat in lieu of skin produced similar results with the 
exception being that significant reductions were observed a day earlier, at day 6. The log 
reduction of Salmonella spp. on meat were 0.51 log CFU/cm2 and for Listeria spp. the reductions 
were 0.67 CFU/cm2. The addition of a live protective culture has also been investigated against 
E. coli O157:H7 in chicken meat. Brashears and coworkers (1998) inoculated boneless-skinless 
chicken breast pieces with E.coli O157:H7 and then treated the breast samples by dipping them 
in a solution of L. lactis, followed by storage in refrigerated temperatures for 0, 3, 5 and 7 days. 
The samples treated with L. lactis significantly reduced the E. coli O157:H7 at day 5 as 
compared to the controls, and in addition it was noted that the control samples were putrid 
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In this study, chitosan, caprylic acid and their combination were evaluated as a coating 
treatment for the reduction of Campylobacter jejuni on poultry products.  For the initial screenings, 
chitosan of three different molecular weights (15-50 kDa, 190-310 kDa and 400-600 kDa) were 
evaluated at three concentrations (0.5%, 1.0%, 2.0%) on 2 g chicken skin pieces in order to 
determine the most effective molecular weight/concentration treatment.  In addition, caprylic acid 
at 0.5%, 1.0% and 2.0% was tested for efficacy against Campylobacter jejuni on chicken skin 
pieces.  From these initial screenings a solution of 2% medium molecular weight (190-310 kDa) 
chitosan was chosen for follow up evaluation, as was 1% and 2% caprylic acid.  To assess the short 
term and long term efficacy of 2% medium molecular weight chitosan, 1% caprylic acid, 2% 
caprylic acid individually and in combination, chicken wingettes were inoculated with 
Campylobacter, coated with a given treatment and microbial analysis was performed at 0, 1, 3, 5 
and 7 days post-treatment.  In replicate trials both 1% and 2% caprylic acid continuously reduced 
Campylobacter counts starting at day 3 through day 7 as compared with controls.  Interestingly, 
there was no improved efficacy from the 2% caprylic acid as opposed to the 1% caprylic acid.  The 
coating of the wingettes with 2% medium molecular weight chitosan also produced reductions in 
Campylobacter counts starting at day 3 lasting until day 7.  The combination of either 1% or 2% 
caprylic acid plus 2% medium molecular weight chitosan continuously reduced Campylobacter 
counts starting at day 0 through day 5.  With the exception of a single time point in trial 2 there 
was no observed increase in efficacy between the 1% caprylic acid with chitosan and the 2% 
caprylic acid plus chitosan.  These results demonstrate that the coating of raw poultry products 
with chitosan, caprylic acid or its combination may be an effective treatment option for the 




The contamination of poultry products with Campylobacter spp. has been receiving 
increased attention in the United States from the United States Department of Agriculture (USDA) 
Food Safety and Inspection Service (FSIS). In 2011, in conjunction with the passage of the Food 
Safety Modernization Act (FSMA), the FSIS implemented new performance standards for the 
contamination of chilled carcasses with Campylobacter (FDA, 2011; FSIS, 2011).  In addition to 
this, the Department of Health and Human Services (HHS) initiated the Healthy People 2020 
program which, among other goals, has an objective to reduce the incidence of human 
Campylobacter infection by 33% by the year 2020 (HHS, 2015).  In order to work towards this 
goal FSIS recently enacted additional performance standards for Campylobacter that include the 
testing of raw chicken parts (including breast, thigh, and wing) as well as ground pieces (USDA 
and FSIS, 2015). 
The most recent estimates of foodborne illness incidence from Campylobacter, as 
determined by FoodNet, has calculated a rate of 13.4 per 100,000 people—the Healthy People 
2020 goal is 8.5 (Crim et al., 2015).  When compared against incidence rates from 2006-2008 
Campylobacter infection has risen by 13%, and even with the new programs initiated to address 
Campylobacter in poultry products this rate has remained stagnant for the last 2 years (CDC, 2014, 
2015).  
In the United States, poultry is a main source of protein, the estimated amount of poultry 
consumed per person in 2014 was approximately 45 kg (National Chicken Council, 2015).  As a 
consequence of the large volume of poultry consumed, the potential for foodborne illness is 
increased even if the rate of contamination is low (Painter et al., 2013).  Modern poultry processing 
involves many sequential steps and procedures which can lead to fecal contamination or cross-
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contamination of carcasses—while this potential for contamination exists, it is currently an 
unavoidable consequence in the practice of producing poultry meat (Corry and Atabay, 2001; 
Sampers et al., 2008; Elvers et al., 2011; Alonso-Hernando et al., 2013).  To date there are no 
consistent, effective methods for the elimination of Campylobacter from the gastrointestinal tract 
of broiler chickens, the result of which is more focus on the options for post-harvest treatments to 
reduce contamination of poultry from bacterial pathogens (Wagenaar et al., 2015).  It has been 
suggested that the greatest effect on reduction of human Campylobacter illness can be obtained 
not from focusing on prevention of the infection of chicken, but by reducing the level of 
Campylobacter on carcasses and raw poultry products (Nauta et al., 2009).  Simulations involving 
multiple intervention options and their predicted effect on the human incidence rate of 
Campylobacter have proposed that a 2 log decrease in the amount of Campylobacter on the carcass 
should lead to a 30x decrease in human infection (Rosenquist et al., 2003; Lindqvist and Lindblad, 
2008; Loretz et al., 2010).   
The application of antimicrobial coatings onto the surface of raw poultry for the reduction 
of pathogens, including Campylobacter, may be an additional intervention to supplement post-
harvest decontamination treatments on poultry carcasses (Ricke and Hanning, 2013).  An edible 
coating is most frequently a liquid in which proteins, polysaccharides or lipids are suspended and 
applied to the food product by dipping, spraying or spreading—the coating is then treated as part 
of the final product to be consumed and classified as a food additive (McHugh, 2000; Han and 
Gennadios, 2005).  Chitosan is a molecule with many physical and biological attributes which may 
be utilized by the poultry industry to increase the food safety of their products.  Characteristics of 
chitosan which are desirable for the food industry include its relative abundance, ability to form 
gels and films, antimicrobial and antifungal activity, GRAS designation and ability to have other 
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antimicrobial compounds incorporated into it (Aider, 2010; Kong et al., 2010; Sánchez-González 
et al., 2011; Elsabee and Abdou, 2013).  Menconi and colleagues (2013) were able to reduce 
Salmonella Typhimurium and show improvements in shelf-life of chicken skin treated with a 
solution of 0.5% chitosan. 
The ability of chitosan to be combined with other antimicrobial compounds and applied as 
a coating to poultry products offers great potential—the possible synergism between the two 
compounds may increase the antimicrobial effect as compared to each compound individually 
(Elsabee and Abdou, 2013).  Research into the application of chitosan coatings in combination 
with natural compounds has demonstrated promising results.  Chitosan and its combination with 
thyme essential oil was able to reduce overall levels of spoilage bacteria and Enterobacteriaceae 
on raw retail chicken kebabs after 12 days of storage (Giatrakou et al., 2010).  Raw chicken breasts 
have shown improvements in shelf-life by the coating of chitosan plus plant derived antimicrobials 
including cinnamon, oregano, clove, and rosemary (Fernández-Pan et al., 2014).   
Fatty acids are being investigated for their potential to reduce pathogens in food products.  
The medium chain fatty acid caprylic acid has reported broad spectrum antibacterial activity 
against many foodborne illness causing bacteria including Salmonella spp., Escherichia coli, 
Listeria monocytogenes and Campylobacter spp. (Kabara et al., 1972; McLay et al., 2002; Nair et 
al., 2005; Skrivanova, 2007).  Caprylic acid is naturally found in mammalian milk and coconut 
oil—additionally it has GRAS status as conferred by the FDA for use in foods (Jensen et al., 1990; 
Sprong et al., 2001; USDA FSIS, 2015).  When used as an antimicrobial treatment for Salmonella 
on chicken skin, it was found that a 0.75mg/mL dose was able to reduce Salmonella during 
sampling at 1, 2 and 3 days post treatment (Skřivanová et al., 2012).  In trials by Riedel and 
colleagues (2009) the application of a 5.0% solution of caprylic acid sodium salt reduced 
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Campylobacter counts on chicken skin and legs by 2.84 log and 4 log, respectively, after treatment 
and 24 hours storage at 40C. 
The objective of the present study was to evaluate the antimicrobial activity of chitosan, 
caprylic acid or their combination to reduce Campylobacter on chicken skin and wingettes for its 
potential use as a post-harvest intervention. 
Materials and Methods 
Preparation of Campylobacter jejuni Inoculum 
A frozen wild type strain of Campylobacter jejuni, previously isolated by our laboratory, 
was used as the inoculum for this study.  One loopful of frozen glycerol stock of the wild-type 
strain Campylobacter jejuni was inoculated into 5 mL of Campylobacter Enrichment Broth (CEB, 
Neogen, Lansing, MI) and incubated at 420C in a microaerophilic atmosphere (5% 02, 10% CO2, 
and 85% N2) for 48 hours.  The Campylobacter inoculum for each trial was prepared as described 
by Akins and colleagues (2009).  Briefly, an aliquot of Campylobacter in CEB was transferred to 
a biphasic culture condition consisting of a Mueller Hinton agar (Difco, Sparks, MD) coated cell 
culture flask with an overlay of Mueller Hinton broth (Difco, Sparks, MD) and incubated at 420C 
for 12 hours in a microaerophilic atmosphere.  At each inoculation time point, an aliquot of 
biphasic grown Campylobacter was centrifuged at 3000 rpm for 12 minutes, the supernatant 
discarded and the cell pellet resuspended in 2x the volume of the original aliquot in Butterfield’s 




Powdered chitosan of high molecular weight (400-600 kDa) and 90% deacetylation was 
purchased from Spectrum Chemical (Spectrum Chemical Mfg. Corp., Gardena, CA).  Medium 
molecular weight chitosan powder was 190-310 kDa (75%-85% deacetylated) and procured from 
Sigma (Sigma-Aldrich, Co., St. Louis, MO) and the low molecular weight chitosan was 15-50 
kDa, at least 85% deacetylated, and purchased from Polysciences, Inc. (Polysciences, Inc., 
Warrington, PA).  Caprylic acid was purchased from Acros Organics (Thermo Fisher Scientific 
Inc., Geel Belgium). 
Preparation of the High, Medium and Low Molecular Weight Chitosan Coating Treatments 
Chitosan solutions were prepared according to a previously published method (Upadhyay 
et al., 2014).  A 50 mM solution of acetic acid was prepared with glacial acetic acid (BDH Aristar, 
West Chester, PA) in deionized water (vol/vol).  To prepare the treatments each molecular weight 
of powdered chitosan was solubilized in 50 mM acetic acid to make a 0.5% (wt/vol), 1.0% (wt/vol) 
or 2.0% (wt/vol) solution, the pH was adjusted as necessary with HCl (Fisher Scientific) to obtain 
complete solubilization and stirred overnight at room temperature to ensure complete 
incorporation of the chitosan powder.  The 50 mM acetic acid control was pH adjusted as necessary 
with 10N NaOH to be similar to the chitosan treatments. 
Evaluation of Antimicrobial Activity of Chitosan on Chicken Skin 
Chicken thigh skin was obtained from commercially available bone-in skin-on chicken 
thighs.  The skin was removed from the muscle tissue and cut into 2 g pieces which were then 
stored at -200C until needed.  On the day of the experiment the skin pieces were allowed to reach 
room temperature and then attached to clips which were equidistantly mounted on a rod.  Coating 
of the chicken skin pieces was based on the protocol by Olaimat and colleagues (2014) with minor 
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modifications.  While attached to the clips, the skin pieces were laid flat on a piece of aluminum 
foil and 50 µl (~1x107 CFU/mL) total volume of the Campylobacter inoculum was added dropwise 
across the surface on each piece of skin.  The skin samples were kept flat for 30 minutes at room 
temperature to allow time for the Campylobacter to adhere to the skin.  For each treatment group 
the rod with the clips and skin attached was raised, allowing all skin samples to hang freely without 
contact to each other and then lowered over a rack holding 50 mL conical tubes with 10 mL of 
treatment solution in each tube.  This allowed the skin samples to be dipped into each treatment 
tube simultaneously.  Chicken skin pieces were dipped into treatment groups which included 50 
mM acetic acid (chitosan control), 0.5% HMW, MMW or LMW chitosan; 1.0% HMW, MMW or 
LMW chitosan and 2.0% HMW, MMW or LMW chitosan.  For each treatment group, the 
inoculated skin samples were simultaneously dipped into 10 mL of treatment in 50 mL conical 
tubes with a contact time of 5 minutes followed directly by air drying for 30 minutes, after which 
point in time each skin sample was individually placed into a sterile sample bag and held at 40C 
for 18 hours until sampled for microbial analysis. There were 5 chicken skin samples per treatment. 
Antimicrobial Efficacy of Caprylic Acid on Chicken Skin 
The antimicrobial effect of caprylic acid was evaluated the same as above with the few 
modifications being: treatments were 0.5%, 1% or 2% caprylic acid prepared in BPD (vol/vol) and 
the control was BPD alone.  Treatment solutions were 10 mL aliquots in 50 mL conical tubes and 
the exposure time was 30 seconds, skin pieces were immediately transferred to 50 mL conical 
tubes followed by microbial analysis.  For each treatment 5 chicken skin pieces were tested. 
Preparation of Chitosan, Caprylic Acid and their Combinations as Coating Treatments 
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For the chitosan coating treatment a 2% solution of medium molecular weight chitosan 
(wt/vol) was prepared in 50 mM acetic acid as described previously.  Caprylic acid coating 
treatments were prepared by dilution of stock caprylic acid with BPD (vol/vol) to obtain a 1% or 
2% solution.  The chitosan plus caprylic acid treatments were made by adding equal volumes of 
1% or 2% caprylic acid in BPD with the 2% medium molecular weight chitosan solution.  For the 
combination control of BPD and acetic acid, an equal volume of BPD and 50 mM acetic acid was 
combined.  The 50 mM acetic acid and the BPD plus acetic acid controls were adjusted with 10N 
NaOH as necessary to obtain pH values similar to the chitosan and caprylic acid treatments.   
Coating of Chicken Wingettes 
Whole chicken wings were received from the University of Arkansas Poultry Pilot 
Processing Plant (Fayetteville, AR) and separated into drumettes, wingettes and wing tips.  The 
wingette portion was only utilized in these trials.  Wingettes were stored at -200C.  For each of the 
replicate trials, frozen chicken wingettes were thawed overnight at 40C and on the day of the trial 
were brought to room temperature.  Wingettes were divided into groups of 5 per treatment group.  
To each wingette an inoculum of approximately 50 µl (~1x107 CFU/mL) total volume of 
Campylobacter was added drop wise to the surface and allowed to adhere for 30 minutes.  To coat 
the wingettes, each one individually was placed in a sample bag containing 10 mL of the respective 
treatments.  The treatments included 1% and 2% caprylic acid plus its control (BPD), 2% MMW 
chitosan and 50 mM acetic acid as its control, and finally 1% caprylic acid plus 2% MMW chitosan 
and 2% caprylic acid plus 2% MMW chitosan with a 1:1 BPD:acetic acid control.  Working with 
one treatment group at a time, wingettes were vigorously shaken for 30 seconds in order to obtain 
a complete coating.  After coating, the wingettes were placed on metal drying racks and allowed 
to dry for 15 minutes on one side and then turned over to dry for 15 minutes on the opposite side.  
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To process the day 0 samples microbial analysis was done immediately after a total of 30 minutes 
drying.  For the samples tested at days 1, 3, 5 or 7, wingettes were vacuum sealed by a 
commercially available sealer (Ziploc V021) and stored at 40C until the day of sampling. 
Microbial Analysis 
For all experiments, the samples were diluted with sterile BPD dilution blanks and plated 
using the spread plate technique onto Campylobacter Line agar (Line, 2001) followed by 
incubation at 420C for 48 hours under microaerophilic atmosphere.  For sample testing of the 2 
gram chicken skin pieces, 18 mL of BPD was added to the sample bag or 50 mL conical tube and 
agitated/vortexed for 30 seconds.  The chicken wingettes were individually removed from their 
vacuum packaging and aseptically transferred to a sterile stomacher bag, weighed and an equal 
wt/vol of BPD was added followed by blending for 30 seconds at 250 rpm (Stomacher 400 
Circulator).  For all samples ten-fold serial dilutions were prepared from each initial dilution.  After 
48 hours incubation colonies were enumerated and CFU per milliliter was calculated.  The 
detection limit of the plating assay used in these experiments was 2.0x101 CFU/mL. 
Statistical Analysis 
The C. jejuni counts were log10 transformed (log10 CFU/mL) for analysis to achieve 
homogeneity of variance (Byrd et al., 2003).  Log transformed data were analyzed using ANOVA 
with the PROC MIXED procedure in the SAS statistical software, version 9.3 (SAS Institute Inc., 
Cary, NC).  Treatment and control means were partitioned by LSMEANS analysis (SAS Institute 





Comparison of the Efficacy to Reduce Campylobacter jejuni on Chicken Skin by Dipping in 
Chitosan Solutions 
The 9 total chitosan treatments (3 molecular weights x 3 concentrations) plus the acetic 
acid control were evaluated for anti-Campylobacter activity after a 5 minute contact time followed 
by 18 hours of storage at 40C.  The mean ± SEM log10 CFU/mL counts for low molecular weight 
chitosan at each concentration were: 0.50% (3.72 ± 0.15), 1.0% (3.97 ± 0.14) and 2.0% (3.68 ± 
0.20).  The low molecular weight chitosan solution failed to reduce Campylobacter counts at 0.5%, 
1.0% or 2.0% as compared to the acetic acid control (4.12 ± 0.23).  The medium molecular weight 
chitosan at 0.50% (3.84 ± 0.11) and 1.0% (3.87 ± 0.19) similarly failed to reduce Campylobacter 
counts, however, the 2.0% medium molecular weight chitosan reduced Campylobacter counts by 
approximately 1.3 log10 (3.09 ± 0.35) when compared to acetic acid alone.  High molecular weight 
chitosan at 0.50% (3.84 ± 0.11), 1.0% (3.65 ± 0.17) or 2.0% (3.68 ± 0.10) was also unable to 
reduce Campylobacter counts on the skin by 18 hours as compared to the control. 
Efficacy of Caprylic Acid to Reduce Campylobacter jejuni on Chicken Skin 
Figure 1 shows the effect of caprylic acid at 3 different concentrations to determine its 
immediate efficacy against Campylobacter jejuni on artificially inoculated chicken skin.  The 
lowest concentration (0.50%) caprylic acid failed to reduce Campylobacter counts as compared to 
the BPD control during a 30 second exposure time in all three trials.  The 1% caprylic acid solution 
produce variable results with reductions in Campylobacter counts of 1.44 log10 in trial 1 and 0.57 
log10 in trial 3 as compared with the BPD control.  However, in trial 2 the 1% caprylic acid failed 
to reduce Campylobacter counts in comparison with BPD.  In contrast to the 0.5% and 1.0% 
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caprylic acid solutions, the highest concentration of caprylic acid (2.0%) reduced Campylobacter 
counts in all three trials.  Campylobacter counts were reduced by 1.37 log10, 0.63 log10 and 0.38 
log10 in trials 1, 2 and 3 respectively as compared with the controls.  
Treatment of Chicken Wings with Chitosan, Caprylic Acid or their Combination to Reduce 
Campylobacter 
Further testing was done with the 2% MMW chitosan, 1% caprylic acid and 2% caprylic 
acid, to investigate their potential individually or in combination, as a coating treatment to reduce 
Campylobacter counts on chicken wings with microbial analysis at days 0, 1, 3, 5 and 7.  As shown 
in Table 1, the 1% and 2% caprylic acid treatments alone were able to reduce Campylobacter 
counts at days 0, 3, 5 and 7 when compared to the BPD control, and by day 7 there was a 2.5 log10 
reduction in counts from the 1% and 2% treatments (Table 1).  Similarly, in trial 2 the 1% and 2% 
caprylic acid treatments reduced Campylobacter counts at days 3, 5 and 7 (Table 2).  
In trial 1, the 2% medium molecular weight chitosan coating reduced Campylobacter 
counts on the chicken wings by day 3, 5 and 7, as compared with the acetic acid controls (Table 
1).  In the second trial the chitosan coating reduced Campylobacter counts starting at day 1 and 
reductions were also determined at day 3 and day 5 (Table 2).  In both trials the 2% medium 
molecular weight chitosan coating reduced the Campylobacter counts to at or just above the 
detection limits of the plating assay.  The overall log10 reductions were variable, in trial 1 at day 7 
the reduction was 2.9 log10 and in trial 2 it was a more modest 0.32 log10, in comparison with the 
acetic acid control. 
In contrast to the individual treatments, the combination treatments had efficacy against 
Campylobacter at the earliest time point—with reproducible decreases in Campylobacter counts 
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at day 0 and continually through day 7 in trial 1 (Table 1) and day 0 through 5 in the second trial 
(Table 2).  The Campylobacter counts were reduced by 2.3 log10 for either the 1% or 2% caprylic 
acid plus chitosan coatings in trial 1 at day 0, and in trial 2 at day 0 they were reduced by 0.91 
log10 and 0.64 log10 respectively, as compared with the BPD:acetic acid control.  Overall, for the 
1% caprylic acid plus chitosan the mean log10 reductions ranged from 1.3 log10 to 2.5 log10 over 
all the sampling time points in the first trial and 0.91 log10 to 2.5 log10 reduction during the second 
trial.  The 2% caprylic acid plus chitosan produced similar results, in trial 1 the range in mean 
reductions was 1.3 log10 through 2.5 log10 from day 0 to day 7, and in trial 2 the mean log reductions 
were between 0.43 log10 and 1.7 log10.  
Discussion 
In this study chicken skin pieces or wingettes were used as a model for the treatment of a 
whole carcass to investigate the potential of natural compounds, specifically chitosan and the 
medium chain fatty acid caprylic acid, to reduce Campylobacter on the skin surface.  The coating 
of chicken carcasses and raw poultry products with antimicrobial compounds is a potential 
treatment strategy that could be added to the food safety interventions currently in use to reduce 
the presence of pathogens.  A wash step post-treatment was not included in the skin studies due to 
our interest in evaluation of chitosan and caprylic acid as coating treatments which would not be 
removed after application. 
For the evaluation of chitosan, 9 treatment combinations were evaluated to determine a 
molecular weight and concentration (vol/vol) with the greatest efficacy on the skin itself. Three 
molecular weights of chitosan (400-600 kDa, 190-310 kDa and 15-50 kDa) were evaluated at three 
concentrations (0.5%, 1.0% and 2.0%).  The antimicrobial activity of chitosan is directly related 
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to its average molecular weight and studies have shown that the efficacy of chitosan is also 
dependent upon the particular target microorganism (Zheng and Zhu, 2003; Elsabee and Abdou, 
2013).  In this study Campylobacter on chicken skin was most sensitive to the 190-310 kDa 
chitosan when prepared as a 2% solution.  However, the low (15-50 kDa) and high (400-600 kDa) 
chitosan at any concentration tested (0.5%, 1.0% or 2.0%) were not effective at reducing 
Campylobacter counts on the skin.  During in-vitro studies Ganan and colleagues (2009) were able 
to demonstrate that Campylobacter is highly sensitive to 0.05% solutions of chitosan at molecular 
weights including 120 kDa, 400 kDa and 643 kDa.  It is not entirely unexpected that the 
antimicrobial activity of the various molecular weight chitosan solutions would be different when 
tested in different matrices, as Dutta and coworkers have reported this finding (Dutta et al., 2009).  
The 1.3 log10 reduction in Campylobacter counts from the 2% medium molecular weight (190-310 
kDa) during a 5 minute application time and 18 hours of storage at 40C suggest that this 
combination has the best properties to be used as an antimicrobial coating for chicken carcasses. 
In addition to chitosan, caprylic acid was also evaluated for its potential to act as an 
antimicrobial coating to reduce Campylobacter counts.  The medium chain fatty acid caprylic acid 
was chosen based on its reported broad spectrum antimicrobial activity and its potential 
acceptability by the food industry and consumers (Sprong et al., 2001; Ganan et al., 2009).  
Caprylic acid is a natural compound from cow milk, human milk and coconut oil and additionally 
it has GRAS status from the FDA to be used on foods (Jensen et al., 1990; Sprong et al., 2001; 
USDA FSIS, 2015).  In this trial chicken skin, previously inoculated with Campylobacter was 
dipped into treatments consisting of 0.5%, 1.0% and 2.0% caprylic acid for 30 seconds followed 
by immediate microbial evaluation.  The brief exposure time of the chicken skin pieces (30 
seconds) was chosen as this would more closely reflect the amount of contact time used in 
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industrial in-line poultry processing (Bauermeister et al., 2008).  Among the concentrations tested, 
the most effective treatment was the highest concentration tested (2%) which produced mean log10 
reductions of 1.37 log10, 0.63 log10 and 0.38 log10 over the course of the three trials.  Treatment 
with 1% caprylic acid produced more variable results, with mean reductions of 1.44 log10 and 0.57 
log10 in two of the three trials.  Chicken skin treated with the 0.5% caprylic acid did not reduce 
Campylobacter counts in any of the three trials.  The 2% caprylic acid treatment had immediate 
efficacy on the chicken skin to reduce Campylobacter counts, which shows its potential to be used 
as a food safe natural coating on chicken carcasses or cut up pieces. 
For the final set of trials 2% MMW chitosan and 1% or 2% caprylic acid were selected 
based upon their demonstrated efficacy in the previous tests for evaluation of their potential to 
reduce Campylobacter counts over an extended period of time.  In addition, the selected 
compounds were also assessed for possible synergistic activity by combination of each 
concentration of caprylic acid (1% or 2%) with the 2% MMW chitosan.  Again, the treatment 
protocol did not involve rinsing the wingettes after application of the coating treatments as the 
objective was evaluation of the coating as a final treatment meant to be left on the raw poultry 
product.  Chicken wingettes were chosen as the matrix for these trials as they potentially more 
closely emulate the various surface properties of the whole carcass as compared to a smaller 
discrete section of skin from the thigh area.  The combination of either concentration of caprylic 
acid (1% or 2%) with 2% MMW chitosan reduced Campylobacter counts on the wingettes more 
rapidly than either treatment alone—as evidenced by reduced counts at day 0 with the combination 
treatments but not until day 3 with the individual treatments.  This would lead to speculation that 
there was a possible additive effect when caprylic acid and chitosan are combined into one 
treatment.  In regards to the sustained effect, in trials 1 and 2 the individual caprylic acid treatments 
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reduced Campylobacter counts by day 3 and continually through day 7 to levels below or just 
above the detection threshold, with overall log10 reductions of between 1.67 to 2.53 logs.  
Interestingly there was no noticeable increased efficacy from the 2% caprylic acid as compared to 
the 1% caprylic acid.  Similar to the caprylic acid, the 2% MMW chitosan coating provided long 
acting reductions in Campylobacter counts from day 3 through 7 in trial 1 and day 1 through 5 in 
trial 2. 
In conclusion, the application of a 2% MMW solution of chitosan or caprylic acid at 1% 
or 2% as a coating is effective as an antimicrobial coating treatment to reduce Campylobacter on 
the skin surface.  For a more immediate reduction in Campylobacter on the skin surface a coating 
made from equal volumes of 2% MMW chitosan and caprylic acid provides reductions 
immediately upon application and lasts through at least day 5.  Further evaluation is needed for 
these compounds in areas including shelf-life studies and sensory analysis prior to implementation 
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Figure 3.1. Evaluation of differing concentrations of caprylic acid treatment to reduce 
Campylobacter jejuni on chicken skin1, 2 
 
1C. jejuni log10 counts (mean ± SEM) on chicken skin pieces inoculated with 50 µl (~9x10
7 
CFU/mL) of a single strain of C. jejuni and exposed to a 30 second dipping treatment in 0.5%, 
1.0%, 2.0% caprylic acid or a BPD control followed by serial dilution in BPD and direct plating. 































































Table 3.1.  The efficacy of caprylic acid, chitosan or their combination to reduce Campylobacter counts on chicken wings trial 11, 2 
Treatments 
Day 0 Day 1 Day 3 Day 5 Day 7 
Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL 
BPD control 3.95 ± 0.10a 2.18 ± 0.13a 3.12 ± 0.27a 3.48 ± 0.12a 3.83 ± 0.20a 
1% caprylic acid 2.78 ± 0.39b 2.55 ± 0.24a 1.88 ± 0.17b 2.09 ± 0.32b 1.30 ± 0.00b 
2% caprylic acid 3.00 ± 0.33b 2.17 ± 0.55a 1.92 ± 0.30b 1.52 ± 0.22b 1.30 ± 0.00b 
      
50mM acetic acid control 3.85 ± 0.46a 3.35 ± 0.29a 3.98 ± 0.09a 3.71 ± 0.04a 4.25 ± 0.11a 
2% MMW chitosan 3.30 ± 0.20a 3.46 ± 0.29a 2.38 ± 0.11b 3.01 ± 0.26b 1.30 ± 0.00b 
      
BPD:acetic acid control 4.31 ± 0.29a 3.30 ± 0.33a 3.50 ± 0.18a 4.37 ± 0.07a 3.81 ± 0.25a 
1% caprylic acid +chitosan 1.92 ± 0.08b 1.63 ± 0.33b 2.15 ± 0.29b 2.19 ± 0.16b 1.30 ± 0.00b 
2% caprylic acid +chitosan 2.00 ± 0.13b 1.83 ± 0.15b 1.41 ± 0.24b 1.38 ± 0.05c 1.36 ± 0.06b 
1Individual chicken wings (n=5 per treatment group) were inoculated with 50 µl (~1x107 CFU/mL) of C. jejuni followed by 30 sec. 
coating treatments, 30 min. air drying and vacuum packaging.  Sampling was performed immediately (day 0) and on days 1, 3, 5 or 7 
during which time samples were vacuum sealed and held at 40C.  The Campylobacter jejuni counts were logarithmically transformed 
(log10 CFU/mL) before analysis to achieve homogeneity of variance (Byrd et al., 2003). 
2Data presented as mean ± SEM of log10 C. jejuni counts. 
a, b, c Treatment means within columns and within treatment groups were partitioned by LSMEANS analysis (SAS Institute, 2010) and 
probability of p<0.05 was required for statistical significance. 









Day 0 Day 1 Day 3 Day 5 Day 7 
Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL Log10 CFU/mL 
BPD control 3.86 ± 0.20a 4.11 ± 0.19a 4.58 ± 0.12a 4.54 ± 0.12a 3.45 ± 0.06a 
1% caprylic acid 3.83 ± 0.34a 4.21 ± 0.15a 3.96 ± 0.16b 3.31 ± 0.15b 1.77 ± 0.16b 
2% caprylic acid 4.05 ± 0.13a 3.81 ± 0.09a 3.82 ± 0.09b 2.84 ± 0.21b 1.75 ± 0.26b 
      
50mM acetic acid control 3.92 ± 0.23a 4.56 ± 0.13a 4.53 ± 0.09a 4.61 ± 0.09a 2.25 ± 0.29a 
2% MMW chitosan 4.59 ± 0.29a 3.54  ± 0.20b 2.72 ± 0.21b 2.96 ± 0.19b 1.93 ± 0.20a 
      
BPD:acetic acid control 4.25 ± 0.20a 4.54 ± 0.07a 4.54 ± 0.07a 4.75 ± 0.09a 2.84 ± 0.45a 
1% caprylic acid +chitosan 3.34 ± 0.22b 3.18  ± 0.10b 3.18 ± 0.10b 3.28 ± 0.25b 2.13 ± 0.32a 
2% caprylic acid +chitosan 3.61 ± 0.10b 2.85 ± 0.36b 2.85 ± 0.36b 3.16 ± 0.22b 2.41 ± 0.36a 
1Individual chicken wings (n=5 per treatment group) were inoculated with 50 µl (~1x107 CFU/mL) of C. jejuni followed by 30 sec. 
coating treatments, 30 min. air drying and vacuum packaging.  Sampling was performed immediately (day 0) and on days 1, 3, 5 or 7 
during which time samples were vacuum sealed and held at 40C   The Campylobacter jejuni counts were logarithmically transformed 
(log10 CFU/mL) before analysis to achieve homogeneity of variance (Byrd et al., 2003). 
2Data presented as mean ± SEM of log10 C. jejuni counts. 
a, b, c Treatment means within columns and within treatment groups were partitioned by LSMEANS analysis (SAS Institute, 2010) and 
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The presence of Campylobacter on poultry products remains one of the leading causes for 
foodborne illness in the U.S.  Increased consumer preference for more natural and less processed 
food products has led to an increased focus on alternative forms of improving food safety.  The 
use of lactic acid bacteria (LAB) as a biopreservative or protective culture in food commodities is 
an ancient technology that is safe and natural.  In this study, 13 Lactobacillus spp. isolates were 
screened by a chicken skin dipping model to evaluate for the potential to reduce Campylobacter 
jejuni counts.  From the 13 original isolates four were chosen for further evaluation based upon 
their ability to inhibit Campylobacter counts, in vitro.  Of the four isolates selected three were 
Lactobacillus salivarius and one was Lactobacillus hamsteri. They were evaluated for short term 
and long term efficacy against Campylobacter jejuni in a chicken wingette model.  Chicken 
wingettes were inoculated with Campylobacter jejuni and treated with either a Lactobacillus broth 
culture or a BPD control, and Campylobacter counts were determined at days 0, 1, 3, 5 and 7.  
Many isolates were able to reduce Campylobacter counts by day 3, however two isolates (4 and 





Campylobacter is a common contaminant of poultry carcasses and raw retail poultry 
products (Suzuki and Yamamoto, 2009; USDA FSIS, 2009).  Strong correlation exists between 
foodborne illnesses and consumption of contaminated or mishandled raw/cooked poultry products. 
(Painter et al., 2013; Bondi et al., 2014).  Campylobacter contamination of poultry meat is a 
significant problem because it is consumed as one of the major sources of protein in the United 
States and indeed globally (AVEC, 2013, 2014; National Chicken Council, 2015; USDA and 
Foreign Agricultural Service, 2015).  The implications of this being, increased consumption will 
result in a higher frequency of illness even if the contamination rate is low (Painter et al., 2013).  
This stresses the importance of the need for effective intervention strategies to reduce 
Campylobacter counts on raw poultry. 
The challenge to poultry processors arises from increased consumer demand for minimally 
processed foods while maintaining a microbiologically safe product (Sofos et al., 1998; Davidson 
et al., 2013).  This in turn has led to an increased interest in the use of natural antimicrobials or 
biopreservatives (Holzapfel et al., 1995; Davidson et al., 2014).  An emerging strategy for the 
improvement of food safety without the use of chemicals is by the addition of lactic acid bacteria 
(LAB) as a protective culture or biopreservative.  This method works by introduction of live 
organisms onto the food matrix and the subsequent inhibition of growth of microbial pathogens or 
spoilage organisms, thereby increasing the safety of the food product and extending its shelf-life 
(Holzapfel et al., 1995; Schillinger et al., 1996; Gaggia et al., 2011).  Lactic acid bacteria have a 
long and safe history in regards to foods. Many beneficial microbes have been used for thousands 
of years to produce fermented food (Währen, 1990).  Additionally they are an abundant and normal 
inhabitant of the human and animal gut microbiome (Maragkoudakis et al., 2009).  It is well 
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documented that LAB exert significant antimicrobial activity by various mechanisms including 
secretion of bacteriocins, production of organic acids and hydrogen peroxide (Schillinger et al., 
1996; Gálvez et al., 2010; Garcia et al., 2010; Gaggia et al., 2011).  However, favorable 
characteristics of LAB are generally strain specific and therefore screening of each strain is 
necessary to determine its application (Ljungh and Wadstrom, 2006). Maragkoudakis and 
colleagues (2009) screened 635 LAB from various food sources to assess for the potential to 
function as protective cultures on chicken meat.  Two LAB strains namely, Enterococcus faecium 
and Lactobacillus fermentum significantly reduced Listeria monocytogenes and Salmonella 
Enteritidis when applied on meat.  In addition, no negative effects on the meat quality were 
produced by the probiotic strains (Maragkoudakis et al., 2009). 
Advances in packaging technology now include the use of edible films or coatings.  The 
use of the natural compound chitosan is an appropriate choice for use as an edible coating—it has 
many favorable biological characteristics including broad spectrum antimicrobial and antifungal 
activity, ability to form gels and films and its ability to readily combine with other substances 
(Kong et al., 2010; Aider, 2010; Sánchez-González et al., 2011; Elsabee and Abdou, 2013; 
Azevedo et al., 2014).  Prior research performed in our laboratory has demonstrated that a 2% 
concentration of 190-310 kDa chitosan, when applied as a surface coating, reduces Campylobacter 
jejuni counts on chicken wingettes (first manuscript in this dissertation).  Tapia and colleagues 
(2007) have investigated increasing the functional ability of edible coatings by incorporation of 
the probiotic bacterium Bifidobacterium lactis to be applied to fresh cut fruit, in conclusion they 
found that the culture was able to remain viable at levels greater than 106 CFU/g during 10 days 
of refrigerated storage. 
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This study investigated the potential of previously characterized LAB isolates in reducing 
Campylobacter jejuni on chicken wingettes either alone or in combination with chitosan. 
Materials and Methods 
Isolation and Identification of Poultry Associated Lactobacillus spp. 
 The LAB strains used in this study were previously isolated and characterized in our 
laboratory (Aguiar et al., 2013).  In brief, ceca from healthy broiler chickens were aseptically 
removed and the cecal contents transferred to sterile tubes followed by serial dilution with 
Butterfields Peptone Diluent (BPD).  Dilutions were plated on blood agar plates (BAP, Difco 
Becton Dickinson and Company, MD) and deMan Rogosa and Sharpe Agar (MRS, Difco Becton 
Dickinson and Company, MD) followed by aerobic incubation at 370C for 24 hours.  Isolated 
colonies were selected and repeatedly subcultured on fresh BAP to obtain pure cultures.  Gram 
staining was utilized for the initial identification.  Final identification was made using the Biolog 
system (“Biolog Microbial ID System,”) as previously described (Aguiar et al., 2013).  Isolates 
identified as Lactobacillus spp. were selected and glycerol stock was made and stored at -800C 
(Bielke et al., 2003; Bhaskaran et al., 2011; Aguiar et al., 2013). 
Screening for In-vitro Anti-Campylobacter Activity of Poultry Associated Lactobacillus spp. 
Isolates 
Each Lactobacillus spp. isolate used in this study was previously evaluated for anti-
Campylobacter activity by use of the soft agar overlay method as described below (Gratia, 1936; 
Aguiar et al., 2013; Arsi et al., 2015).  Lactobacillus spp. isolates were initially grown in 5 mL of 
Tryptic Soy Broth (TSB, BBL Becton Dickinson and Company, MD) and incubated aerobically 
for 24 hours at 370C.  Concurrently, glycerol stock of Campylobacter jejuni was inoculated into 5 
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mL of Campylobacter Enrichment Broth (CEB, Neogen, Lansing, MI) and revived for 48 hours at 
420C under microaerophilic (5% 02, 10% CO2, and 85% N2) conditions.  From the 24 hour 
Lactobacillus broth culture 100µl was spot inoculated into the middle of a Tryptic Soy Agar (TSA, 
BBL Becton Dickinson and Company, MD) plate followed by incubation at 370C for 24 hours.  A 
100 µl aliquot of the 48 hour Campylobacter culture was transferred to fresh CEB and incubated 
microaerophilically for 24 hours at 420C.  To produce the overlay, 100 µl of 24 hour 
Campylobacter broth culture was added to 2 mL of pre-melted soft agar (0.65% agar), mixed and 
gently poured over the surface of the previously spot inoculated TSA plate with a Lactobacillus 
culture in the center.  The overlay was briefly allowed to solidify and then the plates were incubated 
in a microaerophilic atmosphere for 48 hours at 420C.  Overlay plates were visually evaluated for 
anti-Campylobacter activity of Lactobacillus cultures by observation of a clear zone of inhibiton 
of Campylobacter in the overlay surrounding the Lactobacillus colony—the larger the zone the 
greater the inhibitory activity of the Lactobacillus culture.  Isolates producing the largest zone 
were selected for further evaluation. 
Preparation of Campylobacter jejuni Inoculum 
A frozen wild type strain of Campylobacter jejuni, previously isolated by our laboratory, 
was used as the inoculum for this study.  One loopful of frozen glycerol stock of the wild-type 
strain Campylobacter jejuni was inoculated into 5 mL of CEB and incubated at 420C in a 
microaerophilic atmosphere for 48 hours.  The Campylobacter inoculum for each trial was 
prepared as described by Akins and colleagues (2009).  Briefly, an aliquot of Campylobacter in 
CEB was transferred to a biphasic culture condition consisting of a Mueller Hinton agar (Difco, 
Sparks, MD) coated cell culture flask with an overlay of Mueller Hinton broth (Difco, Sparks, 
MD) and incubated at 420C for 18 hours in a microaerophilic atmosphere.  At each inoculation 
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time point, an aliquot of biphasic grown Campylobacter was centrifuged at 3000 rpm for 12 
minutes, the supernatant discarded and the cell pellet resuspended in 2x the volume of the original 
aliquot in Butterfield’s Phosphate Diluent (BPD, Difco Becton Dickinson, MD). 
Preparation of Lactobacillus spp. Cultures as Experimental Treatments 
From the glycerol stock of the pure Lactobacillus isolates a loopful was transferred to 5 
mL of MRS broth and incubated for 24 hours at 370C.  One day before the experiment 100 µl of 
the 24 hour culture was inoculated into a larger volume of fresh MRS broth and incubated at 370C 
for 24 hours, after which time 20 mL was dispensed into 50 mL conical tubes (for the skin 
experiment) or 10 mL was transferred to sterile sample bags (for the wingettes) to be used as a 
dipping or coating treatment. 
Evaluation of Antimicrobial Activity of Poultry Associated Lactobacillus spp. on Chicken Skin 
Chicken thigh skin was obtained from commercially available bone-in skin-on chicken 
thighs.  The skin was removed from the muscle tissue and cut into 2g pieces which were then 
stored at -200C until needed.  On the day of the experiment the skin pieces were allowed to reach 
room temperature and then attached to clips which were equidistantly mounted on a rod.  While 
attached to the clips, the skin pieces were laid flat on a piece of aluminum foil and 50 µl (~1x107 
CFU/mL) total volume of the Campylobacter inoculum was added dropwise across the surface 
each piece of skin.  The skin samples were kept flat for 30 minutes at room temperature to allow 
time for Campylobacter attachment to the skin.  For each treatment group the rod with the clips 
and skin attached was raised, allowing all skin samples to hang freely without contact to each other 
and then lowered over a rack holding 50 mL conical tubes with 20 mL of Lactobacillus broth 
culture in each tube.  This allowed the skin samples to be dipped into each treatment tube 
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simultaneously.  For each treatment group (and BPD control) the skin pieces had a contact time of 
5 minutes then removal from the treatment and 2 minutes of drip drying to allow excess treatment 
to be removed from the skin and then directly to microbial analysis. There were 5 chicken skin 
samples per treatment. 
Preparation and Inoculation of Chick Wingettes with Campylobacter jejuni 
Whole chicken wings were received from the University of Arkansas Poultry Pilot 
Processing Plant (Fayetteville, AR) and separated into drumettes, wingettes and wing tips.  The 
wingette portion was only utilized in these trials.  Wingettes were stored at -200C.  For each of the 
replicate trials frozen chicken wingettes were thawed overnight at 40C and on the day of the trial 
were brought to room temperature.  To each wingette an inoculum of 50 µl (~approximately 1x107 
CFU/mL) of Campylobacter jejuni was added drop-wise to the surface and allowed to adhere for 
30 minutes at room temperature. 
Preparation of the Medium Molecular Weight Chitosan Coating Treatment 
Powdered chitosan of 190-310kDa (75%-85% deacetylated) was purchased from Sigma 
(Sigma-Aldrich, Co., St. Louis, MO).  The chitosan solution was prepared according to a 
previously published method (Upadhyay et al., 2014).  A 50mM solution of acetic acid was 
prepared with glacial acetic acid (BDH Aristar, West Chester, PA) in deionized water (vol/vol). 
Medium molecular weight chitosan powder was solubilized in 50mM acetic acid to make a 2.0% 
(wt/vol) solution, the pH was adjusted as necessary with HCl (Fisher Scientific, Pittsburgh, PA) to 
obtain solubilization and stirred overnight at room temperature to ensure complete incorporation 
of the chitosan powder.  The 50mM acetic acid control was pH adjusted as necessary with 10N 
NaOH to be similar to the chitosan treatment. 
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Preparation of the Combination Treatment of 2% MMW Chitosan and Lactobacillus spp. Broth 
Cultures as Coating Treatments 
The chitosan plus Lactobacillus spp. treatments were produced by adding equal volumes 
of each Lactobacillus 24 hour broth culture with the 2% medium molecular weight chitosan 
solution.  For the combination control made up of BPD and acetic acid, an equal volume of BPD 
and 50mM acetic acid was combined.  The 50mM acetic acid and the BPD plus acetic acid controls 
were adjusted with 10N NaOH as necessary to obtain pH values similar to the chitosan and 
Lactobacillus treatments. 
Application of Coating Treatments to Chicken Wingettes 
Wingettes were divided into treatments groups, 5 wingettes per treatment group.  Coating 
of the chicken wingettes was based on the protocol by Olaimat and colleagues (2014) with minor 
adjustments.  Each wingette was individually aseptically transferred to a sample bag containing 10 
mL of treatment or control solution.  Working with one treatment group at a time, the sample bags 
containing the treatment and wingette were vigorously shaken for 30 seconds in order to obtain a 
complete coating.  After coating, the wingettes were placed on metal drying racks and allowed to 
dry for 15 minutes on one side and then turned over to dry for 15 minutes on the opposite side.  To 
process the day 0 samples microbial analysis was performed immediately after a total of 30 
minutes drying.  For the samples tested at days 1, 3, 5 or 7, wingettes were vacuum sealed by a 
commercially available sealer (Ziploc V021) and stored at 40C until the day of sampling. 
For the first set of coating experiments the wingettes were coated with Lactobacillus spp. 
broth cultures or a BPD control.  From these replicate trials two Lactobacillus spp. isolates that 
produced the greatest reduction in Campylobacter counts were chosen for further evaluation.  In 
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the final set of experiments the Lactobacillus cultures alone or in combination with 2% MMW 
chitosan were applied as a coating treatment to wingettes.  The treatments included isolate 1 and 
2 individually and a BPD control, a 2% MMW chitosan treatment alone and its 50 mM acetic acid 
control and lastly the combination of Lactobacillus isolate 1 plus 2% MMW chitosan, 
Lactobacillus isolate 2 combined with 2% MMW chitosan and a control treatment of BPD and 50 
mM acetic acid combined. 
Microbial Analysis 
For all experiments, the samples were diluted with sterile BPD dilution blanks and plated 
using the spread plate technique onto Campylobacter Line agar (Line, 2001) followed by 
incubation at 420C for 48 hours under microaerophilic atmosphere.  For sample testing of the 2 
gram chicken skin pieces, 18 mL of BPD was added to the 50 mL conical tube and 
agitated/vortexed for 30 seconds.  The chicken wingettes were individually removed from their 
vacuum packaging and aseptically transferred to a sterile stomacher bag, weighed and an equal 
wt/vol of BPD was added followed by blending for 30 seconds at 250 rpm (Stomacher 400 
Circulator).  For all samples ten-fold serial dilutions were prepared from each initial dilution.  After 
48 hours incubation colonies were enumerated and CFU per milliliter was calculated.  The 
detection limit of the plating assay used in these experiments was 2.0x101 CFU/mL. 
Statistical analysis 
The C. jejuni counts were log10 transformed (log10 CFU/mL) for analysis to achieve 
homogeneity of variance (Byrd et al., 2003).  Log transformed data was analyzed using ANOVA 
with the PROC MIXED procedure in the SAS statistical software, version 9.3 (SAS Institute Inc., 
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Cary, NC).  Treatment and control means were partitioned by LSMEANS analysis (SAS Institute 
Inc., 2010) and probability of p < 0.05 was required for statistical significance. 
Results 
Evaluation of Lactobacillus spp. Isolates to Reduce Campylobacter Counts on Chicken Skin 
For this study a total of 13 Lactobacillus spp. strains previous isolated, identified and tested 
for in-vitro anti-Campylobacter activity (Arsi et al., 2015) by our laboratory and were chosen for 
further evaluation as a dipping treatment to reduce Campylobacter numbers on artificially 
inoculated chicken skin pieces. 
A total of thirteen isolates were tested in two separate trials for immediate efficacy to 
reduce Campylobacter jejuni counts on chicken skin during a 5 minute exposure to the broth 
culture. In the first trial, out of the 5 Lactobacillus spp. isolates tested (isolates 1-5), isolate 1 failed 
to reduce Campylobacter counts by this testing method, but isolates 2-5 reduced Campylobacter 
counts by 1.31, 1.21, 1.21 and 1.22 log10 CFU/mL respectively when compared to the BPD control 
(Figure 1). In trial 2, an additional 8 Lactobacillus spp. isolates were evaluated and their results 
are shown in Figure 2.  Isolates 7, 9, 11, 12 and 13 did not produce reductions when compared to 
dipping in BPD.  Lactobacillus isolate 6 had a modest reduction of 0.91 log10 CFU/mL and isolates 
8 and 10 had the greatest reductions of 1.37 and 1.24 log10 CFU/mL as compared to the control.  
From these two trials, 4 Lactobacillus isolates (3, 4, 8 and 10) were chosen to investigate their 
potential efficacy at long term reductions in Campylobacter counts using a chicken wingette 
model.  Three of the isolates selected (3, 8 and 10) were identified as Lactobacillus salivarius and 
the fourth isolate (4) was Lactobacillus hamsteri. 
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Determination of Potential Long Term Anti-Campylobacter Activity by Lactobacillus spp. 
Isolates 
Results from the microbial analysis of the treated wingettes are shown in Table 1 and 2.  
All Lactobacillus cultures had variable results on reducing Campylobacter counts on day 0 or 1.  
Isolate 3 was able to reduce Campylobacter counts in both trial 1 and 2 at sampling time points of 
day 3, 5 and 7 as compared to wingettes coated by BPD.  Isolate 10 also had variable results on 
day 0 in trials 1 and 2 and additionally did not reduce Campylobacter counts in either trial at day 
1.  At days 3 and 5, isolate 10 reduced Campylobacter counts on the wingettes by around 1.5 log10 
CFU/mL in both trials 1 and 2.  Campylobacter counts continued to be reduced at day 7 in both 
trials, with a 0.71 log10 CFU/mL reduction in trial 1 and 1.21 log10 CFU/mL in trial 2.  Isolates 4 
and 8 consistently reduced Campylobacter counts starting at day 1 and at each sampling point 
through day 7, in both trials.  Isolate 4 produced the greatest reductions at days 3 and 5—at day 3 
the reductions were 2.48 and 1.62 log10 CFU/mL in trial 1 and 2 respectively and at day 5 
Campylobacter counts were reduced by 1.5 and 1.86 log10 CFU/mL as compared to the control.  
Similarly, isolate 8 had the greatest efficacy at days 3 and 5; the reductions at day 3 were 1.66 and 
1.07 log10 CFU/mL and at day 5 log10 CFU/mL reductions were 1.82 and 2.22. 
Treatment of Chicken Wingettes with Lactobacillus spp. Isolates, Chitosan or their 
Combination to Reduce Campylobacter 
Of the 4 isolates tested for long term efficacy against Campylobacter, 2 were selected 
Lactobacillus hamsteri (4) and Lactobacillus salivarius (8), for additional testing aimed at 
assessing potential synergistic activity between the Lactobacillus isolates and their combination 
with a 2% MMW chitosan solution.  Listed in Table 3 are the Campylobacter counts for each 
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treatment and controls from replicate trials.  Lactobacillus isolate 4, when applied singly, 
decreased the counts at the initial time point (day 0) and continually through the final time point 
(day 7) in both trials as compared to the BPD treatment.  The combination of isolate 4 plus 2% 
MMW chitosan similarly produced reductions at day 0 and consistently through each sampling 
point up to day 7 in both of the trials as compared to its BPD:acetic acid control.  Isolate 8 was 
unable to consistently decrease the Campylobacter counts at day 0 but counts at days 1, 3, 5 and 7 
were less than the control.  Likewise, isolate 8 combined with 2% MMW chitosan did not produce 
consistent reductions at day 0 but counts were decrease at each subsequent sampling point through 
day 7.  The 2% MMW chitosan applied alone was not able to reproducibly lower the 
Campylobacter counts at the first sampling time but each time point thereafter did have counts 
lower than the control treatment.   
Discussion 
Campylobacter continues to be one of the top two bacterial foodborne pathogens which 
causes illness in the U. S. each year (Crim et al., 2015).  Despite many interventions utilized within 
the poultry processing facility, Campylobacter remains a persistent contaminant on raw poultry 
products (Stern et al., 2001).  Poultry producers face a two-fold challenge with the desire to make 
product with an extended shelf-life yet the consumer is concerned about eating a product with 
minimal processing and chemical treatment—all while maintaining a microbiologically safe 
product (Sofos et al., 1998; David et al., 2013; Sakaridis et al., 2014).  A potential strategy for the 
reduction of foodborne pathogens is by the treatment of raw poultry products with protective 
cultures.  In this study we investigated the efficacy of poultry derived Lactobacillus isolates with 




In the first two trials a chicken skin dipping model was utilized to screen 13 Lactobacillus 
isolates with previously demonstrated anti-Campylobacter activity.  The results of these trials 
indicated that select isolates are capable of producing up to a 1.3 log CFU/mL reduction in 
Campylobacter counts after a 5 minute exposure to the broth culture.  Differences in efficacy 
between testing matrices are expected and there are many examples in the literature of lactic acid 
bacteria isolates with antimicrobial activity in a laboratory setting but upon testing in a more 
complex system only a small number of isolates have repeated efficacy (Aguiar et al., 2013; Arsi 
et al., 2015; Bratz et al., 2015).  From this screening assay 4 isolates which produced greater than 
a 1 log reduction in Campylobacter counts were chosen for further evaluation in a chicken wingette 
model.  
The chicken wingette model was used to more closely resemble the heterogeneous nature 
of the skin on a chicken carcass and in addition, the treatment exposure time of 30 seconds more 
closely approximates a realistic exposure time in terms of integrating the coating treatment with 
intervention strategies already in place within the processing plant (Bauermeister et al., 2008; 
Davidson et al., 2014). It should be noted that the protocol for treatment of the wingettes did not 
include a rinse step after exposure to the treatments, as coating of the wingette surface with the 
treatment is meant to be consumed with the product.  To date there is very little literature on the 
use of protective cultures to enhance the shelf-life and food safety of raw poultry products, and 
specifically for Campylobacter jejuni.  Sakaridis and colleagues (2014) evaluated lactic acid 
bacteria (LAB) isolated from poultry carcasses as a protective culture to reduce the growth of 
Salmonella spp. and Listeria monocytogenes on chicken skin and meat.  They selected a single 
Lactobacillus salivarius culture for testing and evaluated the skin and meat from days 1 through 
7.  They did not find significant reductions in the growth of Salmonella or Listeria until day 6, and 
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the reductions at that time point were between 0.51 log10 CFU/cm
2 and 0.71 log10 CFU/cm
2.  
Melero and colleagues (2012, 2013) have evaluated the impact of protective cultures to reduce C. 
jejuni and L. monocytogenes in chicken products.  When a protective culture of Bifidobacterium 
longum was used to treat chicken legs artificially inoculated with C. jejuni and packaged under 
modified atmosphere they observed a reduction in C. jejuni counts (1.09 log CFU/g) between days 
6 – 9 of the study (Melero et al., 2013).  In contrast, during the testing of Lactobacillus isolates 3, 
4, 8 and 10 all of them produced reductions in Campylobacter counts by day 3 and at day 7 the 
range of mean log10 reductions was 0.63 log10 CFU/mL – 1.65 log10 CFU/mL in trial 1 and 0.74 
log10 CFU/mL – 1.21 log10 CFU/mL in trial 2.  The testing of these 4 Lactobacillus isolates has 
demonstrated the effectiveness of using specific lactic acid bacterial cultures as a protective culture 
to reduce the foodborne pathogen C. jejuni.   
In an attempt to improve upon the efficacy of the Lactobacillus isolates when applied as a 
protective culture, Lactobacillus hamsteri (4) and Lactobacillus salivarius (8) were selected to be 
combined with a 2% chitosan solution and applied as a coating on the wingettes.  In earlier work 
done by our laboratory (first manuscript in this dissertation) it was shown that a 2% solution of 
medium molecular chitosan (190-310 kDa) was effective at prolonged reductions in 
Campylobacter counts on chicken wingettes.  Additionally, chitosan is an advantageous choice as 
a surface coating due to its favorable characteristics including gel and film forming capabilities, 
ability to be combined with other compounds and Generally Regarded as Safe (GRAS) status 
(Kong et al., 2010; Aider, 2010; Sánchez-González et al., 2011; Elsabee and Abdou, 2013).  From 
these trials we can observe that both Lactobacillus salivarius (8) and Lactobacillus hamsteri (4) 
when applied singly as a protective culture, reproducibly lower the Campylobacter levels (log10 
CFU/mL) continuously through day 7 (Tables 1, 2 and 3).   
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In conclusion, from this study we have identified 2 isolates, Lactobacillus salivarius and 
Lactobacillus hamsteri, which consistently reduced the number of surviving Campylobacter on 
wingettes and show potential to be used as a protective culture on raw poultry meat to supplement 
the interventions already in use.  Additional testing of these isolates for assessment of their impact 
on sensory characteristics of the poultry products, effects on food spoilage causing bacteria and in 
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Table 4.1.  The efficacy of selected Lactobacillus spp. isolates to reduce C. jejuni counts on 
chicken wingettes trial 11, 2 
Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
BPD 4.00 ± 0.50a 3.68 ± 0.23a 4.53 ± 0.23a 4.65 ± 0.10a 3.13 ± 0.05a 
3 3.75 ± 0.23a 2.51 ± 0.23bc 3.32 ± 0.11b 3.07 ± 0.22b 1.56 ± 0.13c 
4 3.93 ± 0.11a 2.22 ± 0.27c 2.05 ± 0.33c 3.15 ± 0.33b 1.81 ± 0.24c 
8 3.92 ± 0.09a 2.82 ± 0.14bc 2.87 ± 0.16b 2.83 ± 0.14b 1.88  ± 0.18c 
10 3.82 ± 0.17a 3.10 ± 0.34ab 2.94 ± 0.08b 3.14 ± 0.17b 2.42 ± 0.07b 
1Individual chicken wingettes (n=5) were inoculated with 50 µl (~1x107 CFU/mL) of C. jejuni 
followed by 30 sec. coating treatments, 30 min. air drying and vacuum packaging.  Sampling was 
performed immediately (day 0) and on days 1, 3, 5 or 7 during which time samples were vacuum 
sealed and held at 40C.  The Campylobacter jejuni counts were logarithmically transformed (log10 
CFU/mL) before analysis to achieve homogeneity of variance (Byrd et al., 2003). 
2Mean ± SEM log10 C. jejuni counts. 
a, b, c Treatment means within columns and within treatment groups were partitioned by LSMEANS 




Table 4.2.  The efficacy of selected Lactobacillus spp. isolates to reduce C. jejuni counts on 
chicken wingettes trial 21, 2 
Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
BPD 4.36 ± 0.30a 4.35 ± 0.10a 4.17 ± 0.04a 4.38 ± 0.17a 4.38 ± 0.24a 
3 3.47 ± 0.30b 3.73 ± 0.30ab 2.67 ± 0.23b 3.22 ± 0.16b 3.48 ± 0.23b 
4 3.19 ± 0.21b 3.77 ± 0.35ab 2.55 ± 0.34b 2.52 ± 0.25cd 3.64 ± 0.16b 
8 3.38 ± 0.11b 3.47 ± 0.13b 3.10 ± 0.15b 2.16 ± 0.29d 3.40  ± 0.13b 
10 3.15 ± 0.18b 4.06 ± 0.37ab 2.62 ± 0.20b 2.79 ± 0.14bc 3.17 ± 0.34b 
1Individual chicken wingettes (n=5) were inoculated with 50 µl (~1x107 CFU/mL) of C. jejuni 
followed by 30 sec. coating treatments, 30 min. air drying and vacuum packaging.  Sampling was 
performed immediately (day 0) and on days 1, 3, 5 or 7 during which time samples were vacuum 
sealed and held at 40C.  The Campylobacter jejuni counts were logarithmically transformed (log10 
CFU/mL) before analysis to achieve homogeneity of variance (Byrd et al., 2003). 
2Mean ± SEM of log10 C. jejuni counts. 
a, b, c Treatment means within columns and within treatment groups were partitioned by LSMEANS 









Table 4.3.  Reductions in C. jejuni counts after treatment with Lactobacillus spp. isolates (4 or 8), chitosan or their combination on 
chicken wingettes trial 1 and 21, 2 
 Day 0 Day 1 Day 3 Day 5 Day 7 
Treatments Trial 1 Trial 2 Trial 1 Trial 2 Trial 1 Trial 2 Trial 1 Trial 2 Trial 1 Trial 2 
BPD 4.43 ± 0.44a 4.87 ± 0.10a 4.59 ± 0.06a 4.50 ± 0.14a 4.42 ± 0.05a 4.45 ± 0.03a 4.52 ± 0.13a 3.85 ± 0.27a 4.65 ± 0.10a 4.22 ± 0.10a 
4 3.23 ± 0.17b 3.50 ± 0.17b 2.84 ± 0.19c 3.24 ± 0.12b 3.34 ± 0.11b 2.59 ± 0.24c 2.78 ± 0.10b 2.70 ± 0.23b 2.63 ± 0.17c 3.53 ± 0.37b 
8 3.64 ± 0.17ab 3.55 ± 0.20b 3.51 ± 0.07b 3.26 ± 0.18b 3.36 ± 0.31b 3.63 ± 0.09b 2.91 ± 0.12b 3.13 ± 0.27b 3.20 ± 0.17b 3.12 ± 0.12b 
AA* 4.39 ± 0.25a 4.67 ± 0.07a 4.59 ± 0.08a 4.38 ± 0.11a 4.48 ± 0.16a 4.10 ± 0.14a 4.52 ± 0.12a 4.08 ± 0.10a 4.66 ± 0.10a 4.31 ± 0.05a 
2% 
chitosan 
4.26 ± 0.14a 4.02 ± 0.18b 2.71 ± 0.26b 3.78 ± 0.06b 2.95 ± 0.11b 2.74 ± 0.16b 2.90 ± 0.28b 2.31 ± 0.20b 2.89 ± 0.35b 2.47 ± 0.17b 
B:A* 4.25 ± 0.11a 5.22 ± 0.16a 4.54 ± 0.08a 4.78 ± 0.05a 4.69 ± 0.16a 4.47 ± 0.05a 4.46 ± 0.08a 4.25 ± 0.15a 4.69 ± 0.05a 3.35 ± 0.08a 
4ch** 2.88 ± 0.42b 3.87 ± 0.10b 3.00 ± 0.16b 2.77 ± 0.17b 3.71 ± 0.26b 3.10 ± 0.16b 3.37 ± 0.10b 3.39 ± 0.08b 3.50 ± 0.22b 3.39 ± 0.16b 
8ch** 4.06 ± 0.11a 3.41 ± 0.12c 2.92 ± 0.22b 2.95 ± 0.12b 3.62 ± 0.34b 2.82 ± 0.17b 3.00 ± 0.21b 2.97 ± 0.22b 3.10 ± 0.22b 2.98 ± 0.14c 
1Individual chicken wingettes (n=5) were inoculated with 50 µl (~1x107 CFU/mL) of C. jejuni followed by 30 sec. coating treatments, 
30 min. air drying and vacuum packaging.  Sampling was performed immediately (day 0) and on days 1, 3, 5 or 7 during which time 
samples were vacuum sealed and held at 40C.  The Campylobacter jejuni counts were logarithmically transformed (log10 CFU/mL) 
before analysis to achieve homogeneity of variance (Byrd et al., 2003). 
2Mean ± SEM of log10 C. jejuni counts. 
a, b, c Treatment means within columns and within treatment groups were partitioned by LSMEANS analysis (SAS Institute, 2010) and 
probability of p<0.05 was required for statistical significance. 
*AA= 50mM acetic acid control; B:A = BPD:acetic acid control,  





Figure 4.1.  Evaluation of Lactobacillus spp. isolates to reduce Campylobacter jejuni counts on 
chicken skin pieces Trial 11, 2 
 
1C. jejuni log10 counts (mean ± SEM) on chicken skin pieces (n=5) inoculated with approximately 
50 µl (~1 x 107 CFU/mL) of a single strain of C. jejuni and exposed to a Lactobacillus spp. broth 
culture  or BPD control for 5 minutes followed by 2 minutes of drip drying and microbial analysis 
by direct plating. 
a,b,cTreatments with no common superscript differ significantly (p > 0.05). 







































Figure 4.2  Evaluation of Lactobacillus spp. isolates to reduce Campylobacter jejuni counts on 
chicken skin pieces Trial 21, 2 
 
1C. jejuni log10 counts (mean ± SEM) on chicken skin pieces (n=5) inoculated with approximately 
50 µl (~1 x 107 CFU/mL) of a single strain of C. jejuni and exposed to a Lactobacillus spp. broth 
culture  or BPD control for 5 minutes followed by 2 minutes of drip drying and microbial analysis 
by direct plating. 
a,b,cTreatments with no common superscript differ significantly (p > 0.05). 



















































In the United States, foodborne illness from ingestion of Campylobacter is under increased 
scrutiny—it is one of the leading causes of bacterial food poisoning as well as a direct target of the 
Healthy People 2020 federal program which aims to reduce the incidence by 33% in the year 2020.  
Several factors make the reduction of Campylobacter illness a significant challenge; infection with 
Campylobacter is closely associated with mishandling or consumption of contaminated poultry 
products meanwhile poultry meat is one of the mains sources of protein in the U. S. and some 
estimates report that up to 90% of raw retail poultry meat is contaminated with this bacterium. 
Campylobacter is frequently a normal part of the gut microbiota of poultry and to date there are 
no consistent effective treatments to eliminate it from this source.  This emphasizes the need to 
implement post-harvest strategies for ensuring the microbial safety of poultry products. 
In this project we evaluated the efficacy of natural compounds and Lactic Acid Bacteria 
(LAB) to reduce Campylobacter when applied as a coating treatment and evaluated at days 0, 1, 
3, 5 and 7.  As an edible antimicrobial coating, a 2% medium molecular weight (190-310 kDa) 
chitosan solution was effective at sustained (up to day 7) reductions of Campylobacter on surface 
contaminated chicken wingettes.  Also evaluated was caprylic acid, a medium chain fatty acid with 
demonstrated broad spectrum antimicrobial activity.  We found that both 1% and 2% 
concentrations of caprylic acid, when applied as an edible coating, was effective at reducing 
Campylobacter  from day 3 through 7.  When either 1% or 2% caprylic acid was combined with 
2% medium molecular weight chitosan and applied as a coating the efficacy was increased and 
reductions in Campylobacter were observed from day 0 through day 7.   
Also evaluated in this study was the method of applying Lactobacillus spp. isolates onto 
chicken wingettes for reducing Campylobacter.  After screening 13 isolates of Lactobacillus spp. 
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on chicken skin pieces, four specific isolates were chosen for further evaluation in a chicken 
wingette model.  Each of these 4 Lactobacillus isolates reduced Campylobacter on the wingettes 
from day 3 through 7.  Two of the four isolates evaluated (L. salivarius and L. hamsteri) produced 
the most consistent reductions and were therefore chosen to be evaluate when combined with 2% 
medium molecular weight chitosan.  When each Lactobacillus isolate was combined individually 
with a 2% medium molecular weight chitosan solution and applied as a coating to wingettes 
reductions continued to be observed, however there was no increase in efficacy.   
The natural compounds and LAB evaluated in this study show promising potential as 
treatments to reduce the incidence of Campylobacter contamination on poultry products.  Follow-
up testing of these compounds for their effect on the sensory qualities of the poultry products on 
which they are applied is a natural progression of this study. 
